The	O
Megakaryocyte/Platelet-specific	B-DNA
enhancer	I-DNA
of	O
the	O
alpha2beta1	B-DNA
integrin	I-DNA
gene	I-DNA
:	O
two	O
tandem	O
AP1	B-DNA
sites	I-DNA
and	O
the	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
signaling	O
cascade	O
.	O

The	O
alpha2beta1	B-protein
integrin	I-protein
,	O
a	O
collagen	O
receptor	O
on	O
platelets	B-cell_type
and	O
megakaryocytes	B-cell_type
,	O
is	O
required	O
for	O
normal	O
platelet	O
function	O
.	O

Transcriptional	O
regulation	O
of	O
the	O
alpha2	B-DNA
integrin	I-DNA
gene	I-DNA
in	O
cells	O
undergoing	O
megakaryocytic	O
differentiation	O
requires	O
a	O
core	B-DNA
promoter	I-DNA
between	O
bp	O
-30	O
and	O
-92	O
,	O
a	O
silencer	B-DNA
between	O
bp	O
-92	O
and	O
-351	O
,	O
and	O
megakaryocytic	B-DNA
enhancers	I-DNA
in	O
the	O
distal	B-DNA
5	I-DNA
'	I-DNA
flank	I-DNA
.	O

We	O
have	O
now	O
identified	O
a	O
229-bp	B-DNA
region	I-DNA
of	O
the	O
distal	B-DNA
5	I-DNA
'	I-DNA
flank	I-DNA
of	O
the	O
alpha2	B-DNA
integrin	I-DNA
gene	I-DNA
required	O
for	O
high-level	B-cell_type
enhancer	I-cell_type
activity	I-cell_type
in	I-cell_type
cells	I-cell_type
with	O
megakaryocytic	O
features	O
.	O

Two	O
tandem	O
AP1	B-DNA
binding	I-DNA
sites	I-DNA
with	O
dyad	O
symmetry	O
are	O
required	O
for	O
enhancer	O
activity	O
and	O
for	O
DNA-protein	B-protein
complex	I-protein
formation	O
with	O
members	O
of	O
the	O
c-fos/c-jun	B-protein
family	I-protein
.	O

The	O
requirement	O
for	O
AP1	B-protein
activation	O
suggested	O
a	O
role	O
for	O
the	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
(	O
MAPK	B-protein
)	O
signaling	O
pathway	O
in	O
regulating	O
alpha2	B-DNA
integrin	I-DNA
gene	I-DNA
expression	O
.	O

Inhibition	O
of	O
the	O
MAP	B-protein
kinase	I-protein
cascade	O
with	O
PD98059	O
,	O
a	O
specific	O
inhibitor	O
of	O
MAPK	B-protein
kinase	I-protein
1	I-protein
,	O
prevented	O
the	O
expression	O
of	O
the	O
alpha2	B-protein
integrin	I-protein
subunit	I-protein
in	O
cells	O
induced	O
to	O
become	O
megakaryocytic	O
.	O

We	O
provide	O
a	O
model	O
of	O
megakaryocytic	O
differentiation	O
in	O
which	O
expression	O
of	O
the	O
alpha2	B-DNA
integrin	I-DNA
gene	I-DNA
requires	O
signaling	O
via	O
the	O
MAP	B-protein
kinase	I-protein
pathway	O
to	O
activate	O
two	O
tandem	O
AP1	B-DNA
binding	I-DNA
sites	I-DNA
in	O
the	O
alpha2	B-DNA
integrin	I-DNA
enhancer	I-DNA
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

The	NULL
Megakaryocyte/Platelet-Specific	NULL
Enhancer	NULL
of	NULL
the	NULL
«	NULL
,	NULL
B	NULL
,	NULL
Integrin	NULL
Gene	NULL
:	NULL
Two	NULL
Tandem	NULL
API	NULL
Sites	NULL
and	NULL
the	NULL
Mitogen-Activated	NULL
Protein	NULL
Kinase	NULL
Signaling	NULL
Cascade	NULL
By	NULL
Mary	NULL
M.	NULL
Zutter	NULL
,	NULL
Audrey	NULL
D.	NULL
Painter	NULL
,	NULL
and	NULL
Xun	NULL
Yang	NULL
The	NULL
«	NULL
B	NULL
,	NULL
;	NULL
integrin	NULL
,	NULL
a	NULL
collagen	NULL
receptor	NULL
on	NULL
platelets	NULL
and	NULL
megakaryocytes	NULL
,	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
platelet	NULL
function	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
in	NULL
cells	NULL
undergoing	NULL
megakaryocytic	NULL
differentiation	NULL
requires	NULL
a	NULL
core	NULL
promoter	NULL
between	NULL
bp	NULL
-30	NULL
and	NULL
-92	NULL
,	NULL
a	NULL
silencer	NULL
between	NULL
bp	NULL
-92	NULL
and	NULL
-351	NULL
,	NULL
and	NULL
megakaryocytic	NULL
enhancers	NULL
in	NULL
the	NULL
distal	NULL
5	NULL
'	NULL
flank	NULL
.	NULL

We	NULL
have	NULL
now	NULL
identified	NULL
a	NULL
229-bp	NULL
region	NULL
of	NULL
the	NULL
distal	NULL
5	NULL
'	NULL
flank	NULL
of	NULL
the	NULL
«	NULL
;	NULL
integrin	NULL
gene	NULL
required	NULL
for	NULL
high-level	NULL
enhancer	NULL
activity	NULL
in	NULL
cells	NULL
with	NULL
megakaryocytic	NULL
features	NULL
.	NULL

Two	NULL
tandem	NULL
AP1	NULL
binding	NULL
sites	NULL
with	NULL
dyad	NULL
symmetry	NULL
are	NULL
required	NULL
for	NULL
enhancer	NULL
activity	NULL
and	NULL
for	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
with	NULL
members	NULL
of	NULL
the	NULL
c-fos/c-jun	NULL
family	NULL
.	NULL

The	NULL
requirement	NULL
for	NULL
ISTINCT	NULL
MEMBERS	NULL
OF	NULL
the	NULL
integrin	NULL
family	NULL
of	NULL
cell	NULL
adhesion	NULL
receptors	NULL
are	NULL
expressed	NULL
at	NULL
different	NULL
times	NULL
during	NULL
hematopoietic	NULL
differentiation	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
some	NULL
integrin	NULL
receptors	NULL
,	NULL
such	NULL
as	NULL
the	NULL
«	NULL
sB	NULL
;	NULL
integrin	NULL
on	NULL
erythroid	NULL
cells	NULL
,	NULL
is	NULL
required	NULL
for	NULL
differentiation	NULL
;	NULL
the	NULL
expression	NULL
of	NULL
other	NULL
receptors	NULL
,	NULL
such	NULL
as	NULL
oB	NULL
;	NULL
and	NULL
«	NULL
p	NULL
,	NULL
B3	NULL
on	NULL
megakaryocytes	NULL
and	NULL
platelets	NULL
,	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
function	NULL
.	NULL
'	NULL

''	NULL
The	NULL
oB	NULL
;	NULL
integrin	NULL
mediates	NULL
platelet	NULL
adhesion	NULL
to	NULL
collagen	NULL
in	NULL
vessel	NULL
walls	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
normal	NULL
platelet	NULL
plug	NULL
.	NULL
``	NULL

Lack	NULL
of	NULL
oB	NULL
;	NULL
integrin	NULL
expression	NULL
by	NULL
platelets	NULL
,	NULL
either	NULL
due	NULL
to	NULL
congenital	NULL
abnormalities	NULL
or	NULL
the	NULL
development	NULL
of	NULL
myelodysplastic/myeloproliferative	NULL
dis-orders	NULL
,	NULL
is	NULL
associated	NULL
with	NULL
bleeding	NULL
.	NULL

**	NULL
The	NULL
regulation	NULL
of	NULL
integrin	NULL
gene	NULL
expression	NULL
during	NULL
hematopoietic	NULL
differentiation	NULL
,	NULL
specifically	NULL
megakaryocytic	NULL
differentiation	NULL
,	NULL
has	NULL
been	NULL
a	NULL
major	NULL
focus	NULL
of	NULL
our	NULL
laboratory	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
«	NULL
;	NULL
f	NULL
;	NULL
integrin	NULL
is	NULL
exquisitely	NULL
regulated	NULL
by	NULL
distinctly	NULL
different	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
in	NULL
epithe-lial	NULL
cells	NULL
,	NULL
fibroblasts	NULL
,	NULL
megakaryocytes	NULL
,	NULL
and	NULL
platelets	NULL
.	NULL
'	NULL

''	NULL
``	NULL
``	NULL
To	NULL
evaluate	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
differentiation-dependent	NULL
expression	NULL
of	NULL
the	NULL
oB	NULL
;	NULL
integrin	NULL
is	NULL
regulated	NULL
during	NULL
megakaryocytic	NULL
differentiation	NULL
,	NULL
we	NULL
have	NULL
used	NULL
several	NULL
models	NULL
of	NULL
megakaryocytic	NULL
differentiation	NULL
including	NULL
K562	NULL
cells	NULL
,	NULL
a	NULL
pluripotent	NULL
hematopoietic	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
DAMI	NULL
cells	NULL
,	NULL
a	NULL
megakaryocytic	NULL
cell	NULL
line	NULL
.	NULL

'*4	NULL
K562	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
40	NULL
nmol/L	NULL
phorbol	NULL
dibutyrate	NULL
(	NULL
PDB	NULL
)	NULL
acquired	NULL
megakaryocytic	NULL
features	NULL
,	NULL
including	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
platelet/megakaryocyte	NULL
inte-grins	NULL
opps	NULL
and	NULL
oB	NULL
.	NULL

The	NULL
increased	NULL
of	NULL
;	NULL
integrin	NULL
expression	NULL
was	NULL
a	NULL
result	NULL
of	NULL
increased	NULL
steady-state	NULL
levels	NULL
of	NULL
a	NULL
,	NULL
mRNA	NULL
due	NULL
to	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
.	NULL

``	NULL
!	NULL

Characteriza-	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
.	NULL

Submitted	NULL
January	NULL
29	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
October	NULL
19	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
No	NULL
.	NULL

RO1	NULL
HL51450-04	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Mary	NULL
M.	NULL
Zutter	NULL
MD	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
63110	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1600	NULL
AP1	NULL
activation	NULL
suggested	NULL
a	NULL
role	NULL
for	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
signaling	NULL
pathway	NULL
in	NULL
regulating	NULL
a	NULL
integrin	NULL
gene	NULL
expression	NULL
.	NULL

Inhibition	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
cascade	NULL
with	NULL
PD98059	NULL
,	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
MAPK	NULL
kinase	NULL
1	NULL
,	NULL
prevented	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
«	NULL
;	NULL
integrin	NULL
subunit	NULL
in	NULL
cells	NULL
induced	NULL
to	NULL
become	NULL
megakaryocytic	NULL
.	NULL

We	NULL
provide	NULL
a	NULL
model	NULL
of	NULL
megakaryocytic	NULL
differentiation	NULL
in	NULL
which	NULL
expression	NULL
of	NULL
the	NULL
a	NULL
integrin	NULL
gene	NULL
requires	NULL
signaling	NULL
via	NULL
the	NULL
MAP	NULL
kinase	NULL
pathw	NULL
ay	NULL
to	NULL
activate	NULL
two	NULL
tandem	NULL
AP1	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
«	NULL
,	NULL
integrin	NULL
enhancer	NULL
.	NULL

©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

tion	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
showed	NULL
three	NULL
distinct	NULL
regions	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flank	NULL
that	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
.	NULL
'	NULL

>	NULL
'*	NULL
'	NULL
``	NULL
Regulation	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
in	NULL
both	NULL
the	NULL
K562	NULL
and	NULL
DAMI	NULL
cell	NULL
models	NULL
undergoing	NULL
megakaryocyte	NULL
differentiation	NULL
requires	NULL
a	NULL
core	NULL
promoter	NULL
between	NULL
bp	NULL
-30	NULL
and	NULL
-92	NULL
,	NULL
a	NULL
silencer	NULL
between	NULL
bp	NULL
-92	NULL
and	NULL
-351	NULL
,	NULL
and	NULL
additional	NULL
megakaryocytic	NULL
enhancers	NULL
within	NULL
the	NULL
distal	NULL
5	NULL
``	NULL
flank	NULL
.	NULL
'	NULL

4	NULL
``	NULL
8	NULL
Our	NULL
earlier	NULL
studies	NULL
localized	NULL
the	NULL
strong	NULL
megakaryocytic	NULL
enhancer	NULL
to	NULL
the	NULL
region	NULL
between	NULL
bp	NULL
-1426	NULL
and	NULL
-2592	NULL
.	NULL

``	NULL
4	NULL
We	NULL
now	NULL
verify	NULL
that	NULL
the	NULL
1,166-bp	NULL
region	NULL
serves	NULL
as	NULL
an	NULL
enhancer	NULL
in	NULL
the	NULL
irrelevant	NULL
promoter	NULL
construct	NULL
SV40pCAT	NULL
in	NULL
both	NULL
the	NULL
K562	NULL
and	NULL
DAMI	NULL
models	NULL
of	NULL
megakaryocytic	NULL
differentiation	NULL
.	NULL

Enhancer	NULL
activity	NULL
requires	NULL
two	NULL
tandem	NULL
AP1	NULL
binding	NULL
sites	NULL
with	NULL
dyad	NULL
symmetry	NULL
.	NULL

The	NULL
short	NULL
enhancer	NULL
fragment	NULL
containing	NULL
the	NULL
tandem	NULL
AP1	NULL
consensus	NULL
sites	NULL
binds	NULL
members	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
family	NULL
.	NULL

Inhibition	NULL
of	NULL
the	NULL
mitogen	NULL
activation	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
cascade	NULL
prevents	NULL
the	NULL
upregulation	NULL
of	NULL
«	NULL
,	NULL
B	NULL
;	NULL
integrin	NULL
expression	NULL
induced	NULL
by	NULL
PDB	NULL
.	NULL

We	NULL
present	NULL
a	NULL
model	NULL
in	NULL
which	NULL
activation	NULL
of	NULL
the	NULL
MAPK	NULL
cascade	NULL
signals	NULL
via	NULL
c-fos/c-jun	NULL
family	NULL
members	NULL
to	NULL
activate	NULL
a	NULL
,	NULL
integrin	NULL
gene	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
cultures	NULL
and	NULL
transfection	NULL
assays	NULL
.	NULL

-	NULL
The	NULL
K562	NULL
cell	NULL
line	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
the	NULL
DAMI	NULL
cell	NULL
line	NULL
obtained	NULL
from	NULL
Dr	NULL
Robert	NULL
I.	NULL
Handin	NULL
(	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
were	NULL
propagated	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
.	NULL

Megakaryocytic	NULL
differentiation	NULL
was	NULL
induced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
40	NULL
nmol/L	NULL
PDB	NULL
in	NULL
dimethyl	NULL
sulfoxide	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

In	NULL
experiments	NULL
using	NULL
the	NULL
MAPK	NULL
kinase	NULL
1	NULL
inhibitor	NULL
,	NULL
PD98059	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
PD98059	NULL
(	NULL
50	NULL
umol/L	NULL
)	NULL
in	NULL
dimethyl	NULL
sulfoxide	NULL
for	NULL
15	NULL
minutes	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
PDB	NULL
.	NULL

The	NULL
K562	NULL
cell	NULL
line	NULL
was	NULL
transfected	NULL
by	NULL
electroporation	NULL
using	NULL
a	NULL
BTX	NULL
Electro	NULL
Cell	NULL
Manipulator	NULL
600	NULL
(	NULL
BTX	NULL
Inc	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL
``	NULL

''	NULL
Approximately	NULL
1.0	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
transfected	NULL
in	NULL
RPMI	NULL
medium	NULL
containing	NULL
100	NULL
ug/mL	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
30	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
,	NULL
and	NULL
3	NULL
ug	NULL
of	NULL
RSV-luciferase	NULL
DNA	NULL
by	NULL
electroporation	NULL
at	NULL
275	NULL
V	NULL
and	NULL
600	NULL
uF	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
harvested	NULL
after	NULL
48	NULL
hours	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
analyzed	NULL
using	NULL
a	NULL
Monolight	NULL
2010	NULL
luminometer	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laboratory	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
,	NULL
'	NULL
8	NULL
and	NULL
was	NULL
used	NULL
to	NULL
normalize	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Cell	NULL
extracts	NULL
containing	NULL
identical	NULL
amounts	NULL
of	NULL
luciferase	NULL
activity	NULL
were	NULL
then	NULL
assayed	NULL
for	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
(	NULL
CAT	NULL
)	NULL
activity	NULL
using	NULL
the	NULL
standard	NULL
method	NULL
of	NULL
Gorman	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
Acetylation	NULL
of	NULL
chloramphenicol	NULL
was	NULL
quantified	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
.	NULL

Blood	NULL
,	NULL
Vol	NULL
93	NULL
,	NULL
No	NULL
5	NULL
(	NULL
March	NULL
1	NULL
)	NULL
,	NULL
1999	NULL
;	NULL
pp	NULL
1600-1611	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MEGAKARYOCYTE	NULL
ENHANCER	NULL
OF	NULL
THE	NULL
«	NULL
B	NULL
,	NULL
INTEGRIN	NULL
GENE	NULL
Gel	NULL
mobility	NULL
shift	NULL
analysis	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
from	NULL
uninduced	NULL
and	NULL
phorbol-induced	NULL
K562	NULL
cells	NULL
by	NULL
isolating	NULL
nuclei	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

?	NULL
``	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
lysed	NULL
in	NULL
0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
in	NULL
10	NULL
mL	NULL
of	NULL
STKM	NULL
buffer	NULL
(	NULL
30	NULL
%	NULL
sucrose	NULL
,	NULL
40	NULL
mmol/L	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
37	NULL
mmol/L	NULL
KCI	NULL
,	NULL
and	NULL
12	NULL
mmol/L	NULL
MgC1	NULL
;	NULL
)	NULL
.	NULL

After	NULL
pelleting	NULL
,	NULL
the	NULL
nuclei	NULL
were	NULL
washed	NULL
in	NULL
TNM	NULL
buffer	NULL
(	NULL
100	NULL
mmol/L	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
and	NULL
30	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
extracted	NULL
from	NULL
the	NULL
nuclei	NULL
using	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.35	NULL
mol/L	NULL
KCI	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
0.5	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
10	NULL
ug/mL	NULL
aprotinin	NULL
,	NULL
and	NULL
10	NULL
ug/mL	NULL
leupeptin	NULL
.	NULL

After	NULL
incubation	NULL
with	NULL
gentle	NULL
rotation	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
sample	NULL
was	NULL
centrifuged	NULL
at	NULL
100,000g	NULL
for	NULL
2	NULL
hours	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
collected	NULL
and	NULL
the	NULL
concentration	NULL
of	NULL
nuclear	NULL
proteins	NULL
in	NULL
the	NULL
extracts	NULL
was	NULL
determined	NULL
by	NULL
Bradford	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
Laboratory	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
gel-purified	NULL
double-stranded	NULL
75-bp	NULL
DNA	NULL
fragment	NULL
extending	NULL
from	NULL
bp	NULL
-1503	NULL
to	NULL
-1578	NULL
or	NULL
the	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
end-labeled	NULL
with	NULL
using	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
a	NULL
single	NULL
AP1	NULL
consensus	NULL
element	NULL
(	NULL
5'-CGCTTGATGACTCAGCCGGAA-3	NULL
'	NULL
)	NULL
,	NULL
a	NULL
consensus	NULL
element	NULL
with	NULL
a	NULL
2-bp	NULL
mutation	NULL
of	NULL
the	NULL
API	NULL
site	NULL
(	NULL
AP1m	NULL
;	NULL
5'-CGCTTGATGACTTGGCCGGAA-3	NULL
'	NULL
)	NULL
,	NULL
a	NULL
single	NULL
Sp1	NULL
consensus	NULL
element	NULL
(	NULL
5'-ATT	NULL
CGATCGGGGCGGGGCGAGC-3	NULL
'	NULL
)	NULL
,	NULL
or	NULL
an	NULL
early	NULL
growth	NULL
response	NULL
(	NULL
Egr	NULL
)	NULL
consensus	NULL
element	NULL
(	NULL
5'-GGATCCAGCGGGGGCGAGC-GGGGGCGA-3	NULL
'	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotech	NULL
,	NULL
Inc	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Approximately	NULL
1	NULL
to	NULL
2	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
extract	NULL
was	NULL
added	NULL
to	NULL
20,000	NULL
counts	NULL
per	NULL
minute	NULL
of	NULL
labeled	NULL
DNA	NULL
in	NULL
15	NULL
uL	NULL
of	NULL
binding	NULL
buffer	NULL
(	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
25	NULL
mmol/L	NULL
Tris	NULL
HCI	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
100	NULL
mmol/L	NULL
KCI	NULL
,	NULL
5	NULL
mmol/L	NULL
spermidine	NULL
,	NULL
5	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
dithiothreitol	NULL
,	NULL
and	NULL
2	NULL
mmol/L	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

Some	NULL
incubations	NULL
contained	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
DNA	NULL
fragment	NULL
,	NULL
or	NULL
oligonucleotide	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

In	NULL
antibody	NULL
inhibition	NULL
experiments	NULL
,	NULL
the	NULL
indicated	NULL
amount	NULL
of	NULL
anti-c-fos	NULL
or	NULL
anti-c-jun	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotech	NULL
,	NULL
Inc	NULL
)	NULL
was	NULL
preincubated	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
for	NULL
18	NULL
hours	NULL
at	NULL
4°C	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
P-labeled	NULL
probe	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
using	NULL
6	NULL
%	NULL
acrylamide/Bis	NULL
(	NULL
19:1	NULL
)	NULL
in	NULL
Tris	NULL
,	NULL
pH	NULL
8.8	NULL
.	NULL

«	NULL
-CAT	NULL
fusion	NULL
constructs	NULL
.	NULL

The	NULL
pas	NULL
2592-CAT	NULL
and	NULL
pa	NULL
;	NULL
1426-CAT	NULL
constructs	NULL
were	NULL
generated	NULL
by	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
of	NULL
the	NULL
original	NULL
pa	NULL
5000-CAT	NULL
construct	NULL
at	NULL
the	NULL
restriction	NULL
enzyme	NULL
sites	NULL
Stu	NULL
I	NULL
(	NULL
-2592	NULL
)	NULL
and	NULL
Sac	NULL
I	NULL
(	NULL
-	NULL
1426	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
described	NULL
earlier	NULL
.	NULL

'*	NULL
The	NULL
Stu	NULL
I/Sac	NULL
I	NULL
fragment	NULL
was	NULL
then	NULL
inserted	NULL
into	NULL
the	NULL
blunted	NULL
Sal	NULL
I	NULL
site	NULL
within	NULL
the	NULL
multiple	NULL
cloning	NULL
site	NULL
of	NULL
the	NULL
SV40pCAT	NULL
plasmid	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Two	NULL
SV40pCAT	NULL
constructs	NULL
containing	NULL
the	NULL
bp	NULL
-1426	NULL
to	NULL
-2592	NULL
region	NULL
in	NULL
opposite	NULL
orientations	NULL
were	NULL
selected	NULL
by	NULL
restriction	NULL
enzyme	NULL
and	NULL
sequence	NULL
analyses	NULL
.	NULL

A	NULL
series	NULL
of	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
1166	NULL
bp	NULL
(	NULL
bp	NULL
-1426	NULL
to	NULL
-2592	NULL
)	NULL
were	NULL
generated	NULL
by	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
of	NULL
the	NULL
-1426/-2592	NULL
SV40pCAT	NULL
plasmid	NULL
at	NULL
the	NULL
restriction	NULL
sites	NULL
Xmn	NULL
(	NULL
-1842	NULL
)	NULL
,	NULL
Nsi	NULL
(	NULL
-1655	NULL
)	NULL
,	NULL
Mnl	NULL
I	NULL
(	NULL
-1578	NULL
)	NULL
and	NULL
Mva	NULL
I	NULL
(	NULL
-1503	NULL
)	NULL
.	NULL

The	NULL
-1426/-1655	NULL
SV40pCAT	NULL
plasmid	NULL
was	NULL
used	NULL
as	NULL
a	NULL
template	NULL
for	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
to	NULL
generate	NULL
the	NULL
site-specific	NULL
mutations	NULL
that	NULL
disrupt	NULL
the	NULL
AP2	NULL
,	NULL
GATA	NULL
,	NULL
or	NULL
both	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
construct	NULL
.	NULL

The	NULL
-1503/-1578	NULL
SV40pCAT	NULL
construct	NULL
was	NULL
used	NULL
as	NULL
a	NULL
template	NULL
for	NULL
PCR-directed	NULL
mutagenesis	NULL
to	NULL
generate	NULL
the	NULL
constructs	NULL
containing	NULL
site-specific	NULL
mutations	NULL
that	NULL
disrupt	NULL
the	NULL
two	NULL
API	NULL
binding	NULL
sites	NULL
,	NULL
including	NULL
5	NULL
'	NULL
AP1Im	NULL
-1503/-1578	NULL
SV40pCAT	NULL
,	NULL
3	NULL
'	NULL
APim	NULL
-1503/-1578	NULL
SV40pCAT	NULL
,	NULL
and	NULL
Dbl	NULL
AP1m	NULL
-1503/-1578	NULL
SV40pCAT	NULL
.	NULL

The	NULL
following	NULL
5	NULL
'	NULL
primers	NULL
were	NULL
used	NULL
for	NULL
the	NULL
GATA	NULL
and	NULL
AP2	NULL
mutant	NULL
constructs	NULL
:	NULL
GATAm	NULL
(	NULL
5-GTT	NULL
ATT	NULL
TCC	NULL
CCC	NULL
CAC	NULL
CCC	NULL
CAG	NULL
ATT	NULL
TAA	NULL
AAC	NULL
AC-3	NULL
'	NULL
)	NULL
,	NULL
AP2m	NULL
(	NULL
5'-GTT	NULL
ATT	NULL
TCC	NULL
CCC	NULL
TTT	NULL
CCC	NULL
CAG	NULL
AGA	NULL
TAA	NULL
AAC	NULL
AC-3	NULL
'	NULL
)	NULL
,	NULL
or	NULL
the	NULL
AP2-GATAm	NULL
(	NULL
5-GTT	NULL
ATT	NULL
TCC	NULL
CCC	NULL
TTT	NULL
CCC	NULL
CAG	NULL
ATT	NULL
TAA	NULL
AAC	NULL
AC-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
following	NULL
primers	NULL
were	NULL
used	NULL
for	NULL
the	NULL
AP1	NULL
mutant	NULL
constructs	NULL
:	NULL
5'AP1m	NULL
-=1503/-1578	NULL
SV40pCAT	NULL
(	NULL
5'-GAA	NULL
ATG	NULL
TAT	NULL
GGG	NULL
AGT	NULL
GTT	NULL
TGG-3	NULL
'	NULL
)	NULL
,	NULL
3	NULL
'	NULL
AP1m	NULL
-1503/-1578	NULL
SV40pCAT	NULL
(	NULL
5'-CCT	NULL
TC	NULL
TAT	NULL
CGG	NULL
ACT	NULL
GAA	NULL
ATG-3	NULL
'	NULL
)	NULL
,	NULL
and	NULL
Dbl	NULL
AP1m	NULL
-1503/-1578	NULL
SV40pCAT	NULL
(	NULL
5'-CCA	NULL
AAC	NULL
ACT	NULL
CCC	NULL
ATA	NULL
CAT	NULL
TTC	NULL
AGT	NULL
CCG	NULL
ATA	NULL
GAA-3	NULL
'	NULL
)	NULL
.	NULL

A	NULL
common	NULL
3	NULL
'	NULL
primer	NULL
from	NULL
the	NULL
M13	NULL
vector	NULL
sequence	NULL
was	NULL
used	NULL
in	NULL
all	NULL
1601	NULL
reactions	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
completely	NULL
sequenced	NULL
by	NULL
the	NULL
dideoxy-nucleotide	NULL
chain	NULL
termination	NULL
method	NULL
of	NULL
Sanger	NULL
et	NULL
al	NULL
``	NULL
to	NULL
insure	NULL
that	NULL
the	NULL
site-specific	NULL
mutations	NULL
were	NULL
incorporated	NULL
with	NULL
no	NULL
error	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
full-length	NULL
CAT	NULL
construct	NULL
pa	NULL
;	NULL
2592-CAT	NULL
were	NULL
produced	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
.	NULL

-	NULL
Flow	NULL
cytometric	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
uninduced	NULL
K562	NULL
cells	NULL
,	NULL
K562	NULL
cells	NULL
induced	NULL
for	NULL
6	NULL
days	NULL
with	NULL
PDB	NULL
,	NULL
or	NULL
K562	NULL
cells	NULL
incubated	NULL
with	NULL
PD98059	NULL
for	NULL
15	NULL
minutes	NULL
before	NULL
induction	NULL
with	NULL
PDB	NULL
.	NULL

Single	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
)	NULL
in	NULL
PBS	NULL
with	NULL
1.5	NULL
%	NULL
horse	NULL
serum	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
monoclonal	NULL
anti-a	NULL
>	NULL
antibody	NULL
(	NULL
P1E6	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
ug/mL	NULL
for	NULL
45	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
and	NULL
incubated	NULL
with	NULL
2.5	NULL
ug/mL	NULL
of	NULL
a	NULL
secondary	NULL
goat	NULL
antimouse	NULL
coupled	NULL
to	NULL
fluorescein	NULL
(	NULL
Tago	NULL
,	NULL
Inc	NULL
,	NULL
Burlingame	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
45	NULL
minutes	NULL
at	NULL
4°C	NULL
,	NULL
washed	NULL
twice	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
PBS	NULL
.	NULL

Fluorescein-labeled	NULL
cells	NULL
were	NULL
analyzed	NULL
using	NULL
a	NULL
FACScan	NULL
instrument	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

RESULTS	NULL
A	NULL
229-bp	NULL
region	NULL
of	NULL
the	NULL
distal	NULL
5°	NULL
flank	NULL
functions	NULL
as	NULL
an	NULL
a	NULL
;	NULL
integrin	NULL
subunit	NULL
enhancer	NULL
.	NULL

Three	NULL
distinct	NULL
regions	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flank	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
were	NULL
required	NULL
for	NULL
high-level	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
with	NULL
megakaryocytic	NULL
features	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

``	NULL
4	NULL
To	NULL
verify	NULL
that	NULL
the	NULL
region	NULL
between	NULL
bp	NULL
-1426	NULL
and	NULL
-2592	NULL
served	NULL
enhancer	NULL
function	NULL
in	NULL
cells	NULL
with	NULL
megakaryocytic	NULL
features	NULL
,	NULL
the	NULL
1,166-bp	NULL
fragment	NULL
was	NULL
placed	NULL
in	NULL
the	NULL
irrelevant	NULL
promoter	NULL
construct	NULL
SV40pCAT	NULL
in	NULL
both	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
and	NULL
3	NULL
'	NULL
to	NULL
5	NULL
'	NULL
orientations	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
5	NULL
to	NULL
3	NULL
'	NULL
and	NULL
3	NULL
'	NULL
to	NULL
5°	NULL
-1426/-2592	NULL
SV40pCAT	NULL
constructs	NULL
,	NULL
independent	NULL
of	NULL
orientation	NULL
,	NULL
directed	NULL
high-level	NULL
,	NULL
reporter	NULL
gene	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
induced	NULL
with	NULL
phorbol	NULL
dibutyrate	NULL
to	NULL
undergo	NULL
megakaryocytic	NULL
differentiation	NULL
(	NULL
Fig	NULL
2B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
-1426/-2592	NULL
SV40pCAT	NULL
constructs	NULL
directed	NULL
only	NULL
low-level	NULL
CAT	NULL
activity	NULL
in	NULL
uninduced	NULL
K562	NULL
cells	NULL
.	NULL

The	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
1,166-bp	NULL
region	NULL
in	NULL
the	NULL
irrelevant	NULL
SV40pCAT	NULL
construct	NULL
responded	NULL
to	NULL
induction	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
original	NULL
intact	NULL
promoter/	NULL
enhancer	NULL
construct	NULL
containing	NULL
the	NULL
entire	NULL
5	NULL
'	NULL
flank	NULL
of	NULL
the	NULL
a	NULL
,	NULL
integrin	NULL
gene	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
2A	NULL
and	NULL
B	NULL
.	NULL

The	NULL
orientation-independent	NULL
activity	NULL
of	NULL
the	NULL
region	NULL
between	NULL
bp	NULL
-1426	NULL
and	NULL
-2592	NULL
in	NULL
an	NULL
irrelevant	NULL
promoter	NULL
construct	NULL
established	NULL
its	NULL
role	NULL
as	NULL
an	NULL
enhancer	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
elements	NULL
within	NULL
the	NULL
1,166-bp	NULL
region	NULL
were	NULL
required	NULL
for	NULL
enhancer	NULL
activity	NULL
in	NULL
cells	NULL
undergoing	NULL
megakaryocytic	NULL
differentiation	NULL
,	NULL
a	NULL
series	NULL
of	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
-1426/-2592	NULL
SV40pCAT	NULL
construct	NULL
were	NULL
constructed	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
2A	NULL
.	NULL

This	NULL
series	NULL
of	NULL
deletion	NULL
mutants	NULL
localized	NULL
strong	NULL
enhancer	NULL
activity	NULL
to	NULL
the	NULL
region	NULL
between	NULL
bp	NULL
-1426	NULL
and	NULL
-1655	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
SV40pCAT	NULL
in	NULL
uninduced	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

The	NULL
construct	NULL
-1426/-1655	NULL
SV40pCAT	NULL
exhibited	NULL
enhancer	NULL
activity	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
the	NULL
longer	NULL
enhancer	NULL
constructs	NULL
-1426/-1842	NULL
SV40pCAT	NULL
and	NULL
-1426/-2592	NULL
SV40OpCAT	NULL
(	NULL
Fig	NULL
2A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggested	NULL
that	NULL
the	NULL
enhancer	NULL
was	NULL
located	NULL
in	NULL
the	NULL
229-bp	NULL
region	NULL
between	NULL
bp	NULL
-1426	NULL
and	NULL
-1655	NULL
.	NULL

AP2	NULL
and	NULL
GATA	NULL
elements	NULL
do	NULL
not	NULL
mediate	NULL
enhancer	NULL
function	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
this	NULL
229-bp	NULL
region	NULL
showed	NULL
a	NULL
single	NULL
GATA	NULL
box	NULL
between	NULL
bp	NULL
-1628	NULL
to	NULL
-1684	NULL
adjacent	NULL
to	NULL
an	NULL
AP2	NULL
site	NULL
between	NULL
bp	NULL
-1637	NULL
to	NULL
-1644	NULL
and	NULL
two	NULL
tandem	NULL
,	NULL
but	NULL
inversely	NULL
oriented	NULL
AP1	NULL
binding	NULL
sites	NULL
at	NULL
bp	NULL
-1543	NULL
and	NULL
-1557	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
data	NULL
from	NULL
other	NULL
laboratories	NULL
suggesting	NULL
that	NULL
members	NULL
of	NULL
the	NULL
GATA	NULL
family	NULL
are	NULL
involved	NULL
in	NULL
erythro-megakaryocytic	NULL
differentiation	NULL
,	NULL
we	NULL
initially	NULL
focused	NULL
on	NULL
the	NULL
role	NULL
of	NULL
the	NULL
GATA	NULL
and	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1602	NULL
megakaryocyte-specific	NULL
enhancer	NULL
~1655	NULL
~1426	NULL
Topoll	NULL
Topol	NULL
!	NULL

ZUTTER	NULL
,	NULL
PAINTER	NULL
,	NULL
AND	NULL
YANG	NULL
-30	NULL
-961	NULL
-351	NULL
-92	NULL
|+1	NULL
+12	NULL
+193	NULL
|	NULL
1	NULL
14	NULL
1	NULL
|	NULL
T	NULL
I	NULL
T	NULL
Td	NULL
I	NULL
I	NULL
AP2	NULL
Sp1	NULL
Sp1	NULL
1	NULL
AP2	NULL
P	NULL
AP2	NULL
P	NULL
NFi-ike	NULL
-	NULL
AP2	NULL
NF	NULL
-like	NULL
AP2Sp	NULL
Fig	NULL
1	NULL
.	NULL

_	NULL
A	NULL
schematic	NULL
diagram	NULL
of	NULL
the	NULL
distal	NULL
5	NULL
'	NULL
flank	NULL
of	NULL
the	NULL
«	NULL
;	NULL
integrin	NULL
gene	NULL
.	NULL

Identification	NULL
of	NULL
numerous	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
ubiquitous	NULL
as	NULL
well	NULL
as	NULL
megakaryocyte-specific	NULL
transcription	NULL
factors	NULL
are	NULL
show	NULL
n.	NULL
Three	NULL
distinct	NULL
regions	NULL
are	NULL
responsible	NULL
for	NULL
«	NULL
,	NULL
integrin	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
with	NULL
megakaryocytic	NULL
origin	NULL
.	NULL

These	NULL
include	NULL
a	NULL
core	NULL
promoter	NULL
between	NULL
bp	NULL
-30	NULL
and	NULL
-92	NULL
,	NULL
a	NULL
silencer/repressor	NULL
between	NULL
bp	NULL
-92	NULL
and	NULL
-351	NULL
,	NULL
and	NULL
megakaryocyte-specific	NULL
enhancers	NULL
in	NULL
the	NULL
distal	NULL
5	NULL
'	NULL
flank	NULL
between	NULL
bp	NULL
-1426	NULL
and	NULL
-1655	NULL
.	NULL

The	NULL
megakaryocyte-specific	NULL
enhancer	NULL
is	NULL
underlined	NULL
and	NULL
bracketed	NULL
.	NULL

Data	NULL
from	NULL
Zutter	NULL
et	NULL
al	NULL
.	NULL
'	NULL

''	NULL
AP2	NULL
sites	NULL
in	NULL
megakaryocytic	NULL
enhancer	NULL
activity	NULL
.	NULL
``	NULL

''	NULL
To	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
these	NULL
two	NULL
potential	NULL
binding	NULL
sites	NULL
in	NULL
enhancer	NULL
activity	NULL
,	NULL
mutations	NULL
in	NULL
the	NULL
AP2	NULL
site	NULL
,	NULL
the	NULL
GATA	NULL
site	NULL
,	NULL
or	NULL
both	NULL
sites	NULL
that	NULL
are	NULL
known	NULL
to	NULL
eliminate	NULL
protein	NULL
binding	NULL
were	NULL
constructed	NULL
by	NULL
PCR-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
-1426/-1655	NULL
SV40pCAT	NULL
construct	NULL
(	NULL
Fig	NULL
Activity	NULL
of	NULL
the	NULL
mutant	NULL
constructs	NULL
in	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
cells	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
intact	NULL
-1426/-1655	NULL
SV40pCAT	NULL
construct	NULL
in	NULL
uninduced	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
intact	NULL
-1426/-1655	NULL
SV40pCAT	NULL
construct	NULL
in	NULL
uninduced	NULL
K562	NULL
cells	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1.0	NULL
.	NULL

Results	NULL
are	NULL
represented	NULL
as	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
of	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

The	NULL
-1426/-1655	NULL
SV40pCAT	NULL
construct	NULL
directed	NULL
at	NULL
least	NULL
10-fold	NULL
greater	NULL
enhancer	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
induced	NULL
to	NULL
become	NULL
megakaryocytic	NULL
than	NULL
in	NULL
uninduced	NULL
K562	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
loss	NULL
of	NULL
enhancer	NULL
activity	NULL
we	NULL
expected	NULL
upon	NULL
mutation	NULL
of	NULL
the	NULL
AP2	NULL
or	NULL
GATA	NULL
sites	NULL
,	NULL
mutation	NULL
of	NULL
either	NULL
the	NULL
AP2	NULL
site	NULL
,	NULL
the	NULL
GATA	NULL
site	NULL
,	NULL
or	NULL
both	NULL
sites	NULL
increased	NULL
enhancer	NULL
activity	NULL
twofold	NULL
to	NULL
threefold	NULL
in	NULL
both	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
cells	NULL
.	NULL

Clearly	NULL
,	NULL
the	NULL
AP2	NULL
and	NULL
GATA	NULL
sites	NULL
do	NULL
not	NULL
mediate	NULL
enhancer	NULL
activity	NULL
for	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
and	NULL
may	NULL
serve	NULL
to	NULL
diminish	NULL
enhancer	NULL
activity	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Two	NULL
tandem	NULL
,	NULL
inversely	NULL
oriented	NULL
API	NULL
sites	NULL
demonstrate	NULL
full	NULL
enhancer	NULL
activity	NULL
.	NULL

_	NULL
We	NULL
then	NULL
turned	NULL
our	NULL
attention	NULL
to	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
the	NULL
two	NULL
tandem	NULL
API	NULL
sites	NULL
with	NULL
dyad	NULL
symmetry	NULL
located	NULL
between	NULL
bp	NULL
-1543	NULL
and	NULL
-1557	NULL
.	NULL

To	NULL
focus	NULL
only	NULL
on	NULL
the	NULL
two	NULL
tandem	NULL
AP1	NULL
sites	NULL
,	NULL
a	NULL
shorter	NULL
double-stranded	NULL
DNA	NULL
fragment	NULL
extending	NULL
from	NULL
bp	NULL
-1503	NULL
to	NULL
-1578	NULL
that	NULL
included	NULL
both	NULL
API	NULL
binding	NULL
sites	NULL
but	NULL
eliminated	NULL
77	NULL
bp	NULL
of	NULL
the	NULL
5	NULL
'	NULL
region	NULL
including	NULL
the	NULL
GATA	NULL
and	NULL
AP2	NULL
sites	NULL
and	NULL
77	NULL
bp	NULL
of	NULL
3	NULL
'	NULL
sequence	NULL
was	NULL
prepared	NULL
by	NULL
PCR	NULL
and	NULL
placed	NULL
in	NULL
the	NULL
enhancer	NULL
location	NULL
of	NULL
the	NULL
SV40pCAT	NULL
vector	NULL
(	NULL
Fig	NULL
4A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4B	NULL
,	NULL
the	NULL
short	NULL
construct	NULL
-1530/-1578	NULL
SV40pCAT	NULL
that	NULL
lacked	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
elements	NULL
including	NULL
the	NULL
GATA	NULL
and	NULL
AP2	NULL
sites	NULL
contained	NULL
all	NULL
of	NULL
the	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
longer	NULL
construct	NULL
-1426/-1655	NULL
SV40pCAT	NULL
in	NULL
induced	NULL
K562	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
one	NULL
or	NULL
both	NULL
AP1	NULL
sites	NULL
,	NULL
mutations	NULL
of	NULL
either	NULL
the	NULL
5	NULL
'	NULL
AP1	NULL
site	NULL
,	NULL
the	NULL
3	NULL
'	NULL
API	NULL
site	NULL
,	NULL
or	NULL
both	NULL
sites	NULL
were	NULL
prepared	NULL
in	NULL
the	NULL
shorter	NULL
construct	NULL
-1503/-1578	NULL
SV40pCAT	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
4A	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
the	NULL
mutant	NULL
constructs	NULL
to	NULL
direct	NULL
reporter	NULL
gene	NULL
activity	NULL
in	NULL
the	NULL
irrelevant	NULL
promoter	NULL
construct	NULL
SV40pCAT	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
nonmutated	NULL
construct	NULL
-1503/-1578	NULL
SV40pCAT	NULL
and	NULL
the	NULL
longer	NULL
-1426/-1655	NULL
SV40pCAT	NULL
construct	NULL
in	NULL
both	NULL
induced	NULL
and	NULL
uninduced	NULL
K562	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
high	NULL
level	NULL
of	NULL
reporter	NULL
gene	NULL
activity	NULL
generated	NULL
by	NULL
the	NULL
intact	NULL
-1503/-1578	NULL
SV40OpCAT	NULL
construct	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
constructs	NULL
with	NULL
mutations	NULL
of	NULL
either	NULL
the	NULL
5	NULL
'	NULL
AP1	NULL
site	NULL
,	NULL
the	NULL
3	NULL
'	NULL
API	NULL
site	NULL
,	NULL
or	NULL
both	NULL
API	NULL
sites	NULL
was	NULL
markedly	NULL
reduced	NULL
to	NULL
levels	NULL
only	NULL
slightly	NULL
above	NULL
background	NULL
in	NULL
both	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
two	NULL
adjacent	NULL
but	NULL
inversely	NULL
oriented	NULL
API	NULL
binding	NULL
sites	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
in	NULL
K562	NULL
cells	NULL
induced	NULL
to	NULL
become	NULL
megakaryocytic	NULL
.	NULL

The	NULL
tandem	NULL
API	NULL
binding	NULL
sites	NULL
appear	NULL
responsible	NULL
for	NULL
both	NULL
enhancer	NULL
gene	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
induced	NULL
to	NULL
differentiate	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MEGAKARYOCYTE	NULL
ENHANCER	NULL
OF	NULL
THE	NULL
a	NULL
;	NULL
B	NULL
,	NULL
INTEGRIN	NULL
GENE	NULL
A	NULL
meg	NULL
enhancer	NULL
'2592	NULL
1426	NULL
{	NULL
Tae	NULL
a	NULL
,	NULL
,	NULL
integrin	NULL
gene	NULL
Exon	NULL
1	NULL
pa	NULL
,	NULL
2592-CAT	NULL
e	NULL
``	NULL
{	NULL
cat	NULL
)	NULL
2592	NULL
1426	NULL
-	NULL
Sv-40	NULL
,	NULL
:	NULL
+HpCAT	NULL
]	NULL
Sv-40	NULL
pCAT	NULL
~1842	NULL
~1426	NULL
SV-40	NULL
pCAT	NULL
1655	NULL
1426	NULL
SV-40	NULL
pCAT	NULL
1842-1655	NULL
1426	NULL
SV-40	NULL
i	NULL
-1426/-2592	NULL
SV40-pCAT	NULL
2592	NULL
+1842	NULL
~1842/-2592	NULL
SV40-pCAT	NULL
ke-	NULL
--	NULL
1426/1842	NULL
SV40-pCAT	NULL
14261-1655	NULL
SV40-pCAT	NULL
1655/-1842	NULL
SV40-pCAT	NULL
B40	NULL
30	NULL
20	NULL
Relative	NULL
CAT	NULL
Activity	NULL
S	NULL
<	NULL
0	NULL
5	NULL
&	NULL
=r	NULL
>	NULL
&	NULL
pas	NULL
2592-CAT	NULL
~1426/-2592	NULL
SV40-pCAT	NULL
~1842/-2592	NULL
SV40-pCAT	NULL
14261-1842	NULL
SV40-pCAT	NULL
~142687-1655	NULL
SV40-pCAT	NULL
~1655/-1842	NULL
SV40-pCAT	NULL
Fig	NULL
2	NULL
.	NULL

A	NULL
schematic	NULL
diagram	NULL
of	NULL
the	NULL
«	NULL
,	NULL
promoter-CAT	NULL
construct	NULL
and	NULL
the	NULL
megakaryocytic	NULL
enhancer	NULL
in	NULL
the	NULL
irrelevant	NULL
promoter	NULL
construct	NULL
SV40pCAT	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
construct	NULL
pa	NULL
;	NULL
2592-CAT	NULL
contains	NULL
the	NULL
entire	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
from	NULL
bp	NULL
-2592	NULL
to	NULL
+109	NULL
of	NULL
the	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
upstream	NULL
to	NULL
the	NULL
CAT	NULL
structural	NULL
gene	NULL
.	NULL

The	NULL
construct	NULL
-1426/-2592	NULL
SV40pCAT	NULL
consists	NULL
of	NULL
the	NULL
megakaryocyte	NULL
enhancer	NULL
region	NULL
extending	NULL
from	NULL
bp	NULL
-1426	NULL
to	NULL
-2592	NULL
in	NULL
the	NULL
irrelevant	NULL
promoter	NULL
construct	NULL
SV40pCAT	NULL
.	NULL

Constructs	NULL
-1842/-2592	NULL
SV40pCAT	NULL
,	NULL
-1426/-1842	NULL
SV40pCAT	NULL
,	NULL
-1426/-1655	NULL
SV40pCAT	NULL
,	NULL
and	NULL
-1426/	NULL
-1542	NULL
SV40pCAT	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
construct	NULL
-1426/-2592	NULL
SV40pCAT	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
1,166-bp	NULL
region	NULL
of	NULL
the	NULL
distal	NULL
5	NULL
'	NULL
flank	NULL
serves	NULL
as	NULL
a	NULL
megakaryocytic	NULL
enhancer	NULL
.	NULL

The	NULL
constructs	NULL
pa	NULL
;	NULL
2592-CAT	NULL
,	NULL
-1426/	NULL
-2592	NULL
SV40pCAT	NULL
,	NULL
-1842/	NULL
-2592	NULL
SV40pCAT	NULL
,	NULL
-1426/	NULL
-1842	NULL
SV40pCAT	NULL
,	NULL
-1426/-1655	NULL
SV40pCAT	NULL
,	NULL
and	NULL
-1655/-1842	NULL
SV40pCAT	NULL
were	NULL
transfected	NULL
in	NULL
parallel	NULL
w	NULL
ith	NULL
the	NULL
SV40pCAT	NULL
plasmid	NULL
that	NULL
contains	NULL
the	NULL
strong	NULL
viral	NULL
promoter	NULL
SV40	NULL
without	NULL
an	NULL
enhancer	NULL
into	NULL
either	NULL
uninduced	NULL
(	NULL
X	NULL
)	NULL
or	NULL
induced	NULL
(	NULL
MI	NULL
)	NULL
K562	NULL
cells	NULL
.	NULL

Cotransfection	NULL
with	NULL
RSV-luciferase	NULL
was	NULL
used	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

After	NULL
48	NULL
hours	NULL
of	NULL
incubation	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
assayed	NULL
.	NULL

After	NULL
normalization	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
constructs	NULL
was	NULL
determined	NULL
using	NULL
thin-layer	NULL
chromatography	NULL
and	NULL
differential	NULL
extraction	NULL
.	NULL

The	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
of	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
mutated	NULL
constructs	NULL
in	NULL
uninduced	NULL
or	NULL
induced	NULL
K562	NULL
cells	NULL
from	NULL
three	NULL
separate	NULL
experiments	NULL
was	NULL
determined	NULL
relative	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
SV40pCAT	NULL
in	NULL
uninduced	NULL
K562	NULL
cells	NULL
,	NULL
which	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1.0.	NULL
along	NULL
the	NULL
megakaryocyte	NULL
lineage	NULL
and	NULL
for	NULL
the	NULL
low	NULL
level	NULL
of	NULL
reporter	NULL
gene	NULL
activity	NULL
in	NULL
uninduced	NULL
K562	NULL
cells	NULL
.	NULL

To	NULL
further	NULL
demonstrate	NULL
that	NULL
the	NULL
two	NULL
AP1	NULL
sites	NULL
within	NULL
the	NULL
distal	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
are	NULL
required	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
1603	NULL
gene	NULL
in	NULL
cells	NULL
with	NULL
megakaryocytic	NULL
features	NULL
,	NULL
either	NULL
one	NULL
or	NULL
both	NULL
of	NULL
the	NULL
AP1	NULL
binding	NULL
sites	NULL
were	NULL
mutated	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
original	NULL
intact	NULL
a	NULL
,	NULL
integrin	NULL
gene	NULL
promoter/enhancer	NULL
construct	NULL
,	NULL
CAT	NULL
.	NULL

Identical	NULL
mutations	NULL
of	NULL
either	NULL
the	NULL
5	NULL
'	NULL
API	NULL
site	NULL
,	NULL
the	NULL
3	NULL
'	NULL
API	NULL
site	NULL
,	NULL
or	NULL
both	NULL
API	NULL
sites	NULL
,	NULL
as	NULL
outlined	NULL
above	NULL
,	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
original	NULL
pa,2592-CAT	NULL
construct	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
the	NULL
5	NULL
'	NULL
API	NULL
site	NULL
,	NULL
the	NULL
3	NULL
'	NULL
AP1	NULL
site	NULL
,	NULL
or	NULL
both	NULL
AP1	NULL
sites	NULL
completely	NULL
eliminated	NULL
reporter	NULL
gene	NULL
activity	NULL
mediated	NULL
by	NULL
the	NULL
full-length	NULL
construct	NULL
containing	NULL
the	NULL
entire	NULL
5	NULL
'	NULL
flank	NULL
of	NULL
the	NULL
a	NULL
;	NULL
,	NULL
integrin	NULL
gene	NULL
in	NULL
both	NULL
induced	NULL
and	NULL
uninduced	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
,	NULL
just	NULL
as	NULL
it	NULL
did	NULL
for	NULL
the	NULL
simpler	NULL
reporter	NULL
construct	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

The	NULL
two	NULL
API	NULL
sites	NULL
serve	NULL
enhancer	NULL
function	NULL
in	NULL
DAMI	NULL
cells	NULL
.	NULL

The	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
two	NULL
API	NULL
sites	NULL
in	NULL
DAMI	NULL
cells	NULL
,	NULL
another	NULL
model	NULL
of	NULL
megakaryocytic	NULL
differentiation	NULL
,	NULL
was	NULL
estab-lished	NULL
.	NULL

Uninduced	NULL
DAMI	NULL
cells	NULL
express	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
o	NULL
,	NULL
f	NULL
integrin	NULL
.	NULL

In	NULL
DAMI	NULL
cells	NULL
,	NULL
oof	NULL
;	NULL
integrin	NULL
expression	NULL
is	NULL
markedly	NULL
increased	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
PDB	NULL
.	NULL

!	NULL

*	NULL
Reporter	NULL
gene	NULL
activity	NULL
of	NULL
the	NULL
pa,2592-CAT	NULL
construct	NULL
with	NULL
mutations	NULL
of	NULL
the	NULL
5	NULL
'	NULL
API	NULL
site	NULL
,	NULL
the	NULL
3	NULL
'	NULL
API	NULL
site	NULL
,	NULL
and	NULL
both	NULL
API	NULL
sites	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
original	NULL
pa	NULL
;	NULL
,2592-CAT	NULL
construct	NULL
in	NULL
uninduced	NULL
and	NULL
induced	NULL
DAMI	NULL
cells	NULL
.	NULL

The	NULL
paa2592-CAT	NULL
construct	NULL
exhibited	NULL
low	NULL
levels	NULL
of	NULL
reporter	NULL
gene	NULL
activity	NULL
in	NULL
uninduced	NULL
DAMI	NULL
cells	NULL
and	NULL
high	NULL
levels	NULL
of	NULL
reporter	NULL
activity	NULL
in	NULL
induced	NULL
DAMI	NULL
cells	NULL
.	NULL

Mutations	NULL
of	NULL
either	NULL
the	NULL
5	NULL
'	NULL
API	NULL
site	NULL
,	NULL
the	NULL
3	NULL
'	NULL
API	NULL
site	NULL
,	NULL
or	NULL
both	NULL
API	NULL
sites	NULL
completely	NULL
eliminated	NULL
reporter	NULL
gene	NULL
activity	NULL
of	NULL
the	NULL
po	NULL
;	NULL
2592-	NULL
A	NULL
Hess	NULL
1623	NULL
WT	NULL
5'-	NULL
GTTATTTCCCCCCACCCCCAGAGATAAAACAC	NULL
-	NULL
3°	NULL
AP2	NULL
mutant	NULL
5°-	NULL
GTTATTTCCCCCTTTCCCCAGAGATAAAACAC	NULL
-	NULL
3	NULL
'	NULL
GATA	NULL
mutant	NULL
5'-	NULL
GTTATTTCCCCCCACCCCCAGATTTAAAACAC	NULL
-	NULL
3	NULL
'	NULL
AP2-GATA	NULL
mutant	NULL
5'-	NULL
GTTATTTCCCCCTTTCCCCAGATTTAAAACAC	NULL
-	NULL
3	NULL
``	NULL
B	NULL
Uninduced	NULL
induced	NULL
K562	NULL
ﬂ	NULL
+1655	NULL
~1426	NULL
sv40	NULL
10	NULL
-1655	NULL
‘	NULL
14265V40	NULL
cen	NULL
GATA	NULL
mutant	NULL
46	NULL
~1655	NULL
>	NULL
1426	NULL
Sv40	NULL
“	NULL
CAT	NULL
sva0	NULL
pCAT	NULL
)	NULL
-	NULL
o.1*	NULL
04	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
AP2	NULL
and	NULL
GATA	NULL
consensus	NULL
sites	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
diagram	NULL
demonstrates	NULL
the	NULL
sequence	NULL
of	NULL
a	NULL
32-bp	NULL
region	NULL
within	NULL
the	NULL
megakaryocytic	NULL
enhancer	NULL
extending	NULL
between	NULL
bp	NULL
-1623	NULL
and	NULL
-1655	NULL
containing	NULL
the	NULL
intact	NULL
AP2	NULL
and	NULL
GATA	NULL
binding	NULL
sites	NULL
and	NULL
the	NULL
sequence	NULL
of	NULL
3	NULL
mutant	NULL
constructs	NULL
prepared	NULL
by	NULL
PCR	NULL
to	NULL
produce	NULL
mutations	NULL
of	NULL
either	NULL
the	NULL
AP2	NULL
site	NULL
,	NULL
the	NULL
GATA	NULL
site	NULL
,	NULL
or	NULL
both	NULL
AP2	NULL
and	NULL
GATA	NULL
recognition	NULL
sites	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Mutations	NULL
in	NULL
either	NULL
the	NULL
AP2	NULL
site	NULL
,	NULL
the	NULL
GATA	NULL
site	NULL
,	NULL
or	NULL
both	NULL
AP2	NULL
and	NULL
GATA	NULL
sites	NULL
were	NULL
incorporated	NULL
into	NULL
the	NULL
construct	NULL
-1426/-1655	NULL
SV40pCAT	NULL
.	NULL

The	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
mutant	NULL
constructs	NULL
containing	NULL
either	NULL
a	NULL
single	NULL
mutation	NULL
of	NULL
the	NULL
AP2	NULL
site	NULL
,	NULL
GATA	NULL
site	NULL
,	NULL
or	NULL
the	NULL
AP2	NULL
and	NULL
GATA	NULL
sites	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
intact	NULL
-1426/-1655	NULL
SV40pCAT	NULL
in	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
cells	NULL
.	NULL

Cotransfection	NULL
with	NULL
RSV-luciferase	NULL
was	NULL
used	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

After	NULL
48	NULL
hours	NULL
of	NULL
incubation	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
assayed	NULL
.	NULL

After	NULL
normalization	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
constructs	NULL
was	NULL
determined	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
and	NULL
differential	NULL
extraction	NULL
.	NULL

The	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
of	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
mutant	NULL
constructs	NULL
from	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
electroporations	NULL
w	NULL
as	NULL
determined	NULL
relative	NULL
to	NULL
-1426/	NULL
-1655	NULL
SV40pCAT	NULL
in	NULL
uninduced	NULL
K562	NULL
cells	NULL
,	NULL
which	NULL
was	NULL
assigned	NULL
the	NULL
value	NULL
of	NULL
1.0	NULL
.	NULL

+1426/-1655	NULL
SV40	NULL
pCAT	NULL
10.6	NULL
*	NULL
2.0	NULL
AP2	NULL
mutant	NULL
AP2-GATA	NULL
mutant	NULL
1.3	NULL
%	NULL
0.3	NULL
SV40	NULL
pCAT	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1604	NULL
A	NULL
1570	NULL
1530	NULL
wT	NULL
5'-	NULL
@	NULL
GTTCCAAACACTTACTCACATTTCAGTGAGTCAGAAGGA	NULL
-	NULL
3	NULL
S'AP1	NULL
mutant	NULL
5°-	NULL
GTTCCAAACACTCCCATACATTTCAGTGAGTCAGAAGGA	NULL
-	NULL
3	NULL
SAPT	NULL
mutant	NULL
5°-GTTCCAAACACTTACTCACATTTCAGTCCGATAGAAGGA	NULL
-	NULL
a	NULL
'	NULL
DBL	NULL
API	NULL
mutant	NULL
5'-	NULL
GTTCCAAACACTCCCATACATTTCAGTCCGATAGAAGGA	NULL
-	NULL
3	NULL
``	NULL
Uninduced	NULL
induced	NULL
k5e2	NULL
Kse2	NULL
855	NULL
``	NULL
426	NULL
syaq	NULL
-1426/-1655	NULL
SV40	NULL
pCAT	NULL
pCAT	NULL
10	NULL
80+	NULL
83.0	NULL
+1578	NULL
1503	NULL
svad	NULL
+1508/-1578	NULL
SV40	NULL
pCAT	NULL
i	NULL
--	NULL
--	NULL
-	NULL
80	NULL
%	NULL
20	NULL
_	NULL
22270	NULL
1578	NULL
1503	NULL
``	NULL
000	NULL
gvap	NULL
5'APim	NULL
15037-1578	NULL
SV40	NULL
pCAT	NULL
-a-	NULL
o4	NULL
%	NULL
02	NULL
2	NULL
1578	NULL
41509	NULL
``	NULL
00	NULL
avag	NULL
15087-1578	NULL
8V40	NULL
pCAT	NULL
.	NULL

i	NULL
--	NULL
--	NULL
pGAT	NULL
]	NULL
-	NULL
f2zos	NULL
-	NULL
1.1	NULL
%	NULL
08	NULL
1578	NULL
sos	NULL
``	NULL
DbI	NULL
APim	NULL
15037-1578	NULL
SV40	NULL
pCAT	NULL
0.3*	NULL
0.08	NULL
1.0	NULL
%	NULL
0.5	NULL
sv40	NULL
ro-	NULL
SV40	NULL
pCAT	NULL
0.5	NULL
%	NULL
0.3	NULL
0.25	NULL
%	NULL
0.09	NULL
Fig	NULL
4	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
of	NULL
tandem	NULL
AP1	NULL
consensus	NULL
binding	NULL
sites	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
diagram	NULL
demonstrates	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
40-bp	NULL
region	NULL
of	NULL
the	NULL
a	NULL
,	NULL
enhancer	NULL
extending	NULL
from	NULL
bp	NULL
-1530	NULL
bp	NULL
to	NULL
-1570	NULL
containing	NULL
the	NULL
two	NULL
intact	NULL
but	NULL
inversely	NULL
oriented	NULL
AP1	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
three	NULL
mutant	NULL
constructs	NULL
prepared	NULL
by	NULL
PCR	NULL
containing	NULL
mutations	NULL
of	NULL
the	NULL
5	NULL
``	NULL
AP1	NULL
site	NULL
,	NULL
the	NULL
3	NULL
'	NULL
AP1	NULL
site	NULL
,	NULL
or	NULL
both	NULL
AP1	NULL
binding	NULL
sites	NULL
is	NULL
demonstrated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
To	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
one	NULL
or	NULL
both	NULL
AP1	NULL
sites	NULL
in	NULL
enhancer	NULL
activity	NULL
,	NULL
mutations	NULL
of	NULL
either	NULL
the	NULL
5	NULL
'	NULL
AP1	NULL
site	NULL
,	NULL
the	NULL
3	NULL
'	NULL
AP1	NULL
site	NULL
,	NULL
or	NULL
both	NULL
sites	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
shorter	NULL
construct	NULL
-1503/-1578	NULL
SV40pCAT	NULL
.	NULL

This	NULL
shorter	NULL
construct	NULL
includes	NULL
both	NULL
AP1	NULL
binding	NULL
sites	NULL
but	NULL
eliminates	NULL
77	NULL
bp	NULL
of	NULL
the	NULL
5	NULL
'	NULL
region	NULL
including	NULL
the	NULL
GATA	NULL
and	NULL
AP2	NULL
site	NULL
and	NULL
77	NULL
bp	NULL
of	NULL
3	NULL
'	NULL
sequence	NULL
.	NULL

The	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
original	NULL
-1426/-1655	NULL
SV40pCAT	NULL
construct	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
shorter	NULL
intact	NULL
construct	NULL
-1503/-1578	NULL
SV40pCAT	NULL
and	NULL
the	NULL
three	NULL
mutant	NULL
constructs	NULL
,	NULL
5°	NULL
AP1m	NULL
-1503/-1578	NULL
SV40pCAT	NULL
,	NULL
3	NULL
'	NULL
AP1m	NULL
-1503/	NULL
-1578	NULL
SV40pCAT	NULL
,	NULL
and	NULL
Dbl	NULL
AP1m	NULL
-1503/-1578	NULL
SV40pCAT	NULL
in	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
cells	NULL
after	NULL
transient	NULL
transfection	NULL
.	NULL

Cotransfection	NULL
with	NULL
RSV-luciferase	NULL
w	NULL
as	NULL
used	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

After	NULL
48	NULL
hours	NULL
of	NULL
incubation	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
assayed	NULL
after	NULL
normalization	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

CAT	NULL
activity	NULL
of	NULL
the	NULL
constructs	NULL
was	NULL
determined	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
and	NULL
differential	NULL
extraction	NULL
.	NULL

The	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
of	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
mutant	NULL
constructs	NULL
from	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
electroporations	NULL
w	NULL
as	NULL
determined	NULL
relative	NULL
to	NULL
the	NULL
-1426/-1655	NULL
SV40pCAT	NULL
construct	NULL
in	NULL
uninduced	NULL
K562	NULL
cells	NULL
,	NULL
which	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1.0.	NULL
meq	NULL
enhancer	NULL
ZUTTER	NULL
,	NULL
PAINTER	NULL
,	NULL
AND	NULL
YANG	NULL
CAT	NULL
construct	NULL
in	NULL
uninduced	NULL
and	NULL
induced	NULL
DAMI	NULL
cells	NULL
as	NULL
well	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
provide	NULL
additional	NULL
evidence	NULL
that	NULL
the	NULL
tandem	NULL
API	NULL
sites	NULL
located	NULL
in	NULL
the	NULL
distal	NULL
5	NULL
'	NULL
flank	NULL
of	NULL
the	NULL
«	NULL
;	NULL
integrin	NULL
gene	NULL
are	NULL
required	NULL
for	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
activity	NULL
in	NULL
hematopoietic	NULL
cells	NULL
either	NULL
poised	NULL
to	NULL
become	NULL
megakaryocytic	NULL
or	NULL
induced	NULL
with	NULL
phorbol	NULL
dibutyrate	NULL
to	NULL
acquire	NULL
megakaryocytic	NULL
features	NULL
.	NULL

DNA-protein	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
tandem	NULL
API	NULL
binding	NULL
sites	NULL
.	NULL

To	NULL
identify	NULL
transcription	NULL
factors	NULL
that	NULL
specifically	NULL
interact	NULL
with	NULL
the	NULL
a	NULL
,	NULL
integrin	NULL
enhancer	NULL
,	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
cells	NULL
to	NULL
the	NULL
75-bp	NULL
double-stranded	NULL
DNA	NULL
fragment	NULL
(	NULL
bp	NULL
-1503	NULL
to	NULL
-1578	NULL
)	NULL
containing	NULL
the	NULL
two	NULL
tandem	NULL
API	NULL
sites	NULL
was	NULL
evaluated	NULL
by	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

Nuclear	NULL
proteins	NULL
from	NULL
both	NULL
uninduced	NULL
K562	NULL
cells	NULL
and	NULL
K562	NULL
cells	NULL
induced	NULL
to	NULL
differentiate	NULL
for	NULL
4	NULL
days	NULL
with	NULL
phorbol	NULL
dibutyrate	NULL
bound	NULL
the	NULL
75-bp	NULL
enhancer	NULL
element	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
both	NULL
uninduced	NULL
K562	NULL
cells	NULL
and	NULL
K562	NULL
cells	NULL
induced	NULL
with	NULL
phorbol	NULL
dibutyrate	NULL
formed	NULL
a	NULL
complex	NULL
of	NULL
intermediate	NULL
migration	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
K562	NULL
cells	NULL
also	NULL
formed	NULL
a	NULL
faster	NULL
migrating	NULL
complex	NULL
(	NULL
C	NULL
)	NULL
that	NULL
was	NULL
not	NULL
as	NULL
prominent	NULL
with	NULL
extracts	NULL
from	NULL
induced	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
K562	NULL
cells	NULL
induced	NULL
to	NULL
develop	NULL
megakaryocytic	NULL
features	NULL
bound	NULL
the	NULL
75-bp	NULL
DNA	NULL
fragment	NULL
to	NULL
form	NULL
an	NULL
additional	NULL
,	NULL
slower	NULL
migrating	NULL
complex	NULL
(	NULL
A	NULL
)	NULL
that	NULL
was	NULL
not	NULL
as	NULL
abundant	NULL
with	NULL
extracts	NULL
from	NULL
uninduced	NULL
cells	NULL
.	NULL

Formation	NULL
of	NULL
all	NULL
three	NULL
DNA-protein	NULL
complexes	NULL
could	NULL
be	NULL
specifically	NULL
inhibited	NULL
by	NULL
the	NULL
unlabeled	NULL
75-bp	NULL
DNA	NULL
fragment	NULL
but	NULL
not	NULL
by	NULL
an	NULL
irrelevant	NULL
119-bp	NULL
double-stranded	NULL
DNA	NULL
fragment	NULL
.	NULL

The	NULL
unlabeled	NULL
75-bp	NULL
fragment	NULL
containing	NULL
a	NULL
mutation	NULL
of	NULL
the	NULL
5	NULL
'	NULL
API	NULL
site	NULL
,	NULL
the	NULL
3	NULL
'	NULL
API	NULL
site	NULL
,	NULL
or	NULL
both	NULL
API	NULL
sites	NULL
(	NULL
Dbl	NULL
AP1m	NULL
)	NULL
failed	NULL
to	NULL
inhibit	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
6B	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

More	NULL
rapidly	NULL
migrating	NULL
,	NULL
nonspecific	NULL
complexes	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
unlabeled	NULL
DNA	NULL
fragment	NULL
to	NULL
compete	NULL
,	NULL
were	NULL
present	NULL
in	NULL
some	NULL
experiments	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
two	NULL
tandem	NULL
AP1	NULL
consensus	NULL
elements	NULL
in	NULL
the	NULL
enhancer	NULL
suggests	NULL
a	NULL
role	NULL
for	NULL
the	NULL
AP1	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
in	NULL
a	NULL
,	NULL
integrin	NULL
gene	NULL
regulation	NULL
.	NULL

A	NULL
double-stranded	NULL
Uninduced	NULL
Induced	NULL
Uninduced	NULL
Induced	NULL
gr	NULL
_A	NULL
K562	NULL
K5e2	NULL
_DAML	NULL
_	NULL
DAML	NULL
balls	NULL
-2592	NULL
1426	NULL
a	NULL
,	NULL
integrin	NULL
gene	NULL
I	NULL
+	NULL
2592	NULL
pa	NULL
,	NULL
2592-CAT	NULL
1	NULL
10	NULL
*	NULL
0.5	NULL
10	NULL
#	NULL
2	NULL
2.0	NULL
*	NULL
0.8	NULL
8	NULL
*	NULL
2	NULL
,	NULL
«	NULL
2592	NULL
5°	NULL
APim	NULL
pa,2592-CAT	NULL
i	NULL
me	NULL
0.2	NULL
%	NULL
0.1	NULL
0.2	NULL
*	NULL
0.1	NULL
0.2	NULL
*	NULL
0.1	NULL
0.2	NULL
*	NULL
0.01	NULL
,	NULL
2592	NULL
x1	NULL
3°	NULL
APim	NULL
pa,2592-CAT	NULL
1	NULL
CAT	NULL
-	NULL
o.2*01	NULL
0.2	NULL
*	NULL
0.1	NULL
0.2	NULL
*	NULL
0.1	NULL
0.2	NULL
*	NULL
0.01	NULL
~2592	NULL
+4	NULL
Dbl	NULL
APIm	NULL
pa	NULL
,	NULL
2592-CAT	NULL
1	NULL
+HCAT	NULL
0.2	NULL
*	NULL
0.1	NULL
0.3	NULL
*	NULL
0.1	NULL
0.4	NULL
*	NULL
0.1	NULL
0.2	NULL
*	NULL
0.01	NULL
a	NULL
CAT-BASIC	NULL
CA	NULL
10	NULL
10	NULL
*	NULL
0.2	NULL
10	NULL
10	NULL
#	NULL
0.7	NULL
Fig	NULL
5	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
tandem	NULL
AP1	NULL
binding	NULL
sites	NULL
markedly	NULL
reduced	NULL
the	NULL
promoter/enhancer	NULL
activity	NULL
of	NULL
the	NULL
intact	NULL
pe	NULL
;	NULL
2592-CAT	NULL
construct	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
5	NULL
'	NULL
AP1	NULL
site	NULL
,	NULL
the	NULL
3	NULL
'	NULL
AP1	NULL
site	NULL
,	NULL
or	NULL
both	NULL
AP1	NULL
sites	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
original	NULL
p	NULL
«	NULL
;	NULL
,2592-CAT	NULL
construct	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

The	NULL
promoter/enhancer	NULL
activity	NULL
of	NULL
the	NULL
original	NULL
pa	NULL
;	NULL
2592-CAT	NULL
construct	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
construct	NULL
with	NULL
mutations	NULL
in	NULL
the	NULL
5'AP1	NULL
site	NULL
,	NULL
the	NULL
3	NULL
'	NULL
AP1	NULL
site	NULL
,	NULL
or	NULL
both	NULL
AP1	NULL
sites	NULL
after	NULL
transient	NULL
transfection	NULL
into	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
cells	NULL
and	NULL
uninduced	NULL
and	NULL
induced	NULL
DAMI	NULL
cells	NULL
.	NULL

Cotransfection	NULL
with	NULL
RSV-luciferase	NULL
was	NULL
used	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

After	NULL
48	NULL
hours	NULL
of	NULL
incubation	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
assayed	NULL
.	NULL

After	NULL
normalization	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
constructs	NULL
was	NULL
determined	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
and	NULL
differential	NULL
extraction	NULL
.	NULL

The	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
of	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
mutant	NULL
constructs	NULL
in	NULL
either	NULL
K562	NULL
cells	NULL
or	NULL
DAM	NULL
!	NULL

cells	NULL
from	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
electroporations	NULL
was	NULL
determined	NULL
relative	NULL
to	NULL
the	NULL
pCAT-Basic	NULL
construct	NULL
in	NULL
uninduced	NULL
K562	NULL
or	NULL
uninduced	NULL
DAM	NULL
I	NULL
cells	NULL
,	NULL
respectively	NULL
,	NULL
which	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1.0	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MEGAKARYOCYTE	NULL
ENHANCER	NULL
OF	NULL
THE	NULL
a	NULL
;	NULL
B	NULL
,	NULL
INTEGRIN	NULL
GENE	NULL
A	NULL
Probe	NULL
_	NULL
75bp	NULL
enhancer	NULL
(	NULL
bp	NULL
-1578	NULL
to	NULL
-1503	NULL
)	NULL
Nuclear	NULL
K562	NULL
4dind	NULL
extract	NULL
m-	NULL
--	NULL
-	NULL
&	NULL
s	NULL
,	NULL
8	NULL
o	NULL
Inhibitor	NULL
_	NULL
--	NULL
A	NULL
-A	NULL
-R	NULL
AAA	NULL
%	NULL
%	NULL
%	NULL
X	NULL
2	NULL
§	NULL
2	NULL
g	NULL
W	NULL
-A	NULL
Wi	NULL
!	NULL

_	NULL
=	NULL
>	NULL
_	NULL
Su	NULL
-p	NULL
,	NULL
«	NULL
ut	NULL
_	NULL
was	NULL
-C	NULL
1605	NULL
B	NULL
Probe	NULL
_	NULL
75bp	NULL
enhancer	NULL
(	NULL
bp	NULL
-1578	NULL
to	NULL
-1503	NULL
)	NULL
Nuclear	NULL
K562	NULL
4dind	NULL
0	NULL
extract	NULL
=	NULL
``	NULL
2	NULL
-	NULL
z	NULL
im-	NULL
A	NULL
.	NULL

&	NULL
e	NULL
g	NULL
0	NULL
f	NULL
ip	NULL
a	NULL
w	NULL
PS	NULL
]	NULL
Inhibitor	NULL
_	NULL
~-	NULL
-~	NULL
8	NULL
~	NULL
a	NULL
Fig	NULL
6	NULL
.	NULL

-	NULL
Gel	NULL
mobility	NULL
shift	NULL
analysis	NULL
of	NULL
the	NULL
megakaryocyte	NULL
enhancer	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
Gel	NULL
mobility	NULL
shift	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
*°P	NULL
end-labeled	NULL
double-stranded	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
75-bp	NULL
enhancer	NULL
region	NULL
(	NULL
bp	NULL
-1503/-1578	NULL
)	NULL
with	NULL
tw	NULL
o	NULL
tandem	NULL
AP1	NULL
binding	NULL
sites	NULL
and	NULL
1	NULL
mg	NULL
of	NULL
nuclear	NULL
protein	NULL
from	NULL
either	NULL
uninduced	NULL
K562	NULL
cells	NULL
(	NULL
K562	NULL
)	NULL
or	NULL
K562	NULL
cells	NULL
induced	NULL
for	NULL
4	NULL
days	NULL
(	NULL
4d	NULL
Ind	NULL
)	NULL
with	NULL
phorbol	NULL
.	NULL

Three	NULL
major	NULL
DNA	NULL
protein	NULL
complexes	NULL
are	NULL
indicated	NULL
as	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C.	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
formed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitive	NULL
inhibitor	NULL
(	NULL
0	NULL
)	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
non-specific	NULL
(	NULL
NS	NULL
)	NULL
inhibitor	NULL
consisting	NULL
of	NULL
119-bp	NULL
double-stranded	NULL
DNA	NULL
fragment	NULL
from	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
«	NULL
,	NULL
cDNA	NULL
(	NULL
A	NULL
)	NULL
,	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
75-bp	NULL
DNA	NULL
fragment	NULL
containing	NULL
mutations	NULL
to	NULL
both	NULL
AP1	NULL
binding	NULL
sites	NULL
(	NULL
Dbl	NULL
AP1m	NULL
)	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
an	NULL
unlabeled	NULL
specific	NULL
inhibitor	NULL
(	NULL
75	NULL
bp	NULL
)	NULL
inhibited	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

oligonucleotide	NULL
containing	NULL
only	NULL
a	NULL
single	NULL
consensus	NULL
API	NULL
site	NULL
specifically	NULL
bound	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
7A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
complex	NULL
formed	NULL
between	NULL
the	NULL
consensus	NULL
AP1	NULL
oligonucleotide	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
induced	NULL
K562	NULL
cells	NULL
was	NULL
more	NULL
abundant	NULL
than	NULL
the	NULL
complex	NULL
formed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
K562	NULL
cells	NULL
.	NULL

Complex	NULL
formation	NULL
between	NULL
the	NULL
consensus	NULL
API	NULL
site	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
cells	NULL
was	NULL
partially	NULL
inhibited	NULL
by	NULL
10-fold	NULL
and	NULL
almost	NULL
completely	NULL
inhibited	NULL
by	NULL
20-fold	NULL
addition	NULL
of	NULL
the	NULL
identical	NULL
unlabeled	NULL
oligonucleotide	NULL
and	NULL
completely	NULL
inhibited	NULL
by	NULL
10-fold	NULL
or	NULL
20-fold	NULL
addition	NULL
of	NULL
the	NULL
75-bp	NULL
enhancer	NULL
fragment	NULL
but	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
the	NULL
AP1	NULL
consensus	NULL
oligonucleotide	NULL
with	NULL
a	NULL
2-bp	NULL
mutation	NULL
(	NULL
AP	NULL
1m	NULL
;	NULL
Fig	NULL
7A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
Egr	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
failed	NULL
to	NULL
inhibit	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
7B	NULL
)	NULL
.	NULL

Antibodies	NULL
against	NULL
c-fos/c-jun	NULL
heterodimers	NULL
prevent	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
.	NULL

-	NULL
The	NULL
API	NULL
consensus	NULL
element	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
enhancer	NULL
is	NULL
separated	NULL
by	NULL
one	NULL
nucleotide	NULL
(	NULL
TGANTCA	NULL
)	NULL
.3®	NULL
c-fos/c-jun	NULL
heterodimers	NULL
prefer	NULL
such	NULL
DNA	NULL
targets	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
ATF/CREB-containing	NULL
dimers	NULL
prefer	NULL
AP1	NULL
consensus	NULL
elements	NULL
separated	NULL
by	NULL
two	NULL
nucleotides	NULL
(	NULL
TGANNTCA	NULL
)	NULL
.	NULL
``	NULL

''	NULL
Antibodies	NULL
against	NULL
c-fos	NULL
or	NULL
c-jun	NULL
family	NULL
members	NULL
inhibited	NULL
complex	NULL
formation	NULL
between	NULL
K562	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
AP1	NULL
consensus	NULL
site	NULL
,	NULL
but	NULL
not	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
SP1	NULL
or	NULL
NFkB	NULL
consensus	NULL
sites	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
under	NULL
our	NULL
experiment	NULL
conditions	NULL
(	NULL
Fig	NULL
7A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Under	NULL
similar	NULL
experimental	NULL
conditions	NULL
,	NULL
antibodies	NULL
against	NULL
c-fos	NULL
also	NULL
inhibited	NULL
formation	NULL
of	NULL
complexes	NULL
B	NULL
and	NULL
C	NULL
between	NULL
the	NULL
75-bp	NULL
enhancer	NULL
fragment	NULL
and	NULL
uninduced	NULL
K562	NULL
cell	NULL
extracts	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
8	NULL
.	NULL

Anti-c-fos	NULL
antibodies	NULL
inhibited	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
formed	NULL
between	NULL
the	NULL
75-bp	NULL
enhancer	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
induced	NULL
K562	NULL
cells	NULL
.	NULL

An	NULL
antibody	NULL
against	NULL
c-jun	NULL
family	NULL
members	NULL
diminished	NULL
formation	NULL
of	NULL
complex	NULL
B	NULL
formed	NULL
by	NULL
the	NULL
75-bp	NULL
enhancer	NULL
and	NULL
uninduced	NULL
nuclear	NULL
extracts	NULL
and	NULL
formation	NULL
of	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
between	NULL
the	NULL
75-bp	NULL
fragment	NULL
and	NULL
extracts	NULL
from	NULL
induced	NULL
K562	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
members	NULL
of	NULL
the	NULL
c-fos	NULL
and	NULL
c-jun	NULL
family	NULL
bind	NULL
to	NULL
the	NULL
75-bp	NULL
enhancer	NULL
fragment	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ZUTTER	NULL
,	NULL
PAINTER	NULL
,	NULL
AND	NULL
YANG	NULL
1606	NULL
PB	NULL
Probe	NULL
-	NULL
AP1	NULL
concensus	NULL
oligonucieotide	NULL
B	NULL
Probe	NULL
_	NULL
AP1	NULL
concensus	NULL
oligonucleotide	NULL
Nuclear	NULL
K562	NULL
4dind	NULL
extract	NULL
=	NULL
``	NULL
EC	NULL
[	NULL
(	NULL
2	NULL
-	NULL
E00	NULL
[	NULL
[	NULL
2C	NULL
Nuclear	NULL
K562	NULL
4dind	NULL
&	NULL
Lo	NULL
E20	NULL
E42	NULL
io	NULL
&	NULL
E82	NULL
£2	NULL
extract	NULL
__	NULL
thi	NULL
0	NULL
<	NULL
<	NULL
a	NULL
o	NULL
To	NULL
&	NULL
<	NULL
<	NULL
a	NULL
o	NULL
46	NULL
Inhibitor	NULL
1—Hﬁl—nm	NULL
”	NULL
05	NULL
b	NULL
I|—'—	NULL
'	NULL
1	NULL
[	NULL
_1lm	NULL
”	NULL
05	NULL
1	NULL
E	NULL
a	NULL
E	NULL
x6	NULL
)	NULL
xox	NULL
&	NULL
2	NULL
2	NULL
2	NULL
xox	NULL
£	NULL
2	NULL
2s	NULL
2	NULL
ae	NULL
®	NULL
<	NULL
wu	NULL
8	NULL
<	NULL
w	NULL
6	NULL
s	NULL
R	NULL
S	NULL
R	NULL
s	NULL
c	NULL
o	NULL
R	NULL
#	NULL
R	NULL
8	NULL
Inhibitor	NULL
__	NULL
vt	NULL
00	NULL
alel	NULL
ng	NULL
gs	NULL
-	NULL
9	NULL
wos	NULL
a	NULL
ons	NULL
-	NULL
irk	NULL
{	NULL
é	NULL
é	NULL
£51	NULL
é	NULL
-~	NULL
~*	NULL
a	NULL
ci	NULL
«	NULL
wih	NULL
tat	NULL
C	NULL
‘	NULL
--	NULL
-	NULL
Sos	NULL
emaih	NULL
C	NULL
Probe	NULL
AP1	NULL
concensus	NULL
oligonucleotide	NULL
Nuclear	NULL
K562	NULL
4dind	NULL
extract	NULL
_	NULL
_	NULL
8	NULL
``	NULL
_	NULL
8	NULL
“	NULL
&	NULL
C	NULL
_	NULL
in	NULL
L_	NULL
in	NULL
Inhibitor	NULL
&	NULL
.	NULL

,	NULL
<	NULL
,	NULL
~	NULL
,	NULL
&	NULL
,	NULL
<	NULL
X	NULL
X	NULL
X	NULL
X	NULL
86	NULL
5	NULL
6	NULL
6	NULL
oa	NULL
_-	NULL
a	NULL
oa	NULL
-	NULL
a	NULL
Fig	NULL
7	NULL
.	NULL

A	NULL
consensus	NULL
AP1	NULL
site	NULL
forms	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

(	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
Gel	NULL
mobility	NULL
shift	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
*°P	NULL
end-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
single	NULL
AP1	NULL
consensus	NULL
binding	NULL
site	NULL
and	NULL
1	NULL
mg	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
uninduced	NULL
K562	NULL
cells	NULL
(	NULL
K562	NULL
)	NULL
or	NULL
phorbol	NULL
ester-induced	NULL
K562	NULL
cells	NULL
(	NULL
4d	NULL
Ind	NULL
)	NULL
(	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
.	NULL

A	NULL
DNA-protein	NULL
complex	NULL
formed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitive	NULL
inhibitor	NULL
(	NULL
2	NULL
)	NULL
(	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
identical	NULL
oligonucleotide	NULL
with	NULL
a	NULL
2-bp	NULL
mutation	NULL
in	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
(	NULL
AP1m	NULL
)	NULL
(	NULL
A	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
unlabeled	NULL
specific	NULL
75-bp	NULL
enhancer	NULL
region	NULL
(	NULL
bp	NULL
-1503/	NULL
-1578	NULL
)	NULL
with	NULL
two	NULL
tandem	NULL
AP1	NULL
binding	NULL
sites	NULL
(	NULL
C	NULL
)	NULL
,	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
irrelevant	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
early	NULL
growth	NULL
response	NULL
family	NULL
(	NULL
Egr	NULL
)	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
unlabeled	NULL
AP1	NULL
oligonucleotide	NULL
inhibited	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
(	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Monoclonal	NULL
or	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
either	NULL
c-fos	NULL
or	NULL
c-jun	NULL
(	NULL
at	NULL
the	NULL
indicated	NULL
concentration	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
for	NULL
18	NULL
hours	NULL
at	NULL
4°C	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
°P	NULL
end-labeled	NULL
probe	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Antisera	NULL
against	NULL
both	NULL
c-fos	NULL
and	NULL
anti-c-jun	NULL
inhibited	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
.	NULL

The	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
or	NULL
the	NULL
concentration	NULL
of	NULL
antibody	NULL
is	NULL
indicated	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
analyses	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MEGAKARYOCYTE	NULL
ENHANCER	NULL
OF	NULL
THE	NULL
a	NULL
;	NULL
B	NULL
,	NULL
INTEGRIN	NULL
GENE	NULL
Probe	NULL
_	NULL
75bp	NULL
enhancer	NULL
(	NULL
bp	NULL
-1578	NULL
to	NULL
-1503	NULL
)	NULL
Nuclear	NULL
K562	NULL
4dind	NULL
extract	NULL
|	NULL
=-	NULL
z-	NULL
r-	NULL
-	NULL
--	NULL
$	NULL
00	NULL
a	NULL
$	NULL
2	NULL
Inhibitor	NULL
_	NULL
-B	NULL
~-*	NULL
%	NULL
--	NULL
%	NULL
-	NULL
~R	NULL
:	NULL
*-*	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
a	NULL
#	NULL
4	NULL
“	NULL
q	NULL
.	NULL

U	NULL
4	NULL
a	NULL
—A	NULL
w	NULL
wh	NULL
=	NULL
-	NULL
wo	NULL
-	NULL
«	NULL
4	NULL
-B	NULL
@	NULL
@	NULL
-	NULL
aa	NULL
=	NULL
-	NULL
a	NULL
-	NULL
at	NULL
-~©	NULL
«	NULL
uo	NULL
=-	NULL
«	NULL
ih	NULL
«	NULL
ang	NULL
Fig	NULL
8	NULL
.	NULL

Anti-c-fos	NULL
and	NULL
anti-c-jun	NULL
antibodies	NULL
inhibit	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
*P	NULL
end-labeled	NULL
75-bp	NULL
enhancer	NULL
fragment	NULL
(	NULL
bp	NULL
-1578	NULL
to	NULL
bp	NULL
-1503	NULL
)	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
either	NULL
uninduced	NULL
K562	NULL
cells	NULL
(	NULL
K562	NULL
)	NULL
or	NULL
K562	NULL
cells	NULL
induced	NULL
for	NULL
4	NULL
days	NULL
with	NULL
phorbol	NULL
dibutyrate	NULL
(	NULL
4d	NULL
Ind	NULL
)	NULL
.	NULL

Monoclonal	NULL
or	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
either	NULL
c-fos	NULL
or	NULL
c-jun	NULL
(	NULL
at	NULL
the	NULL
indicated	NULL
concentration	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
for	NULL
18	NULL
hours	NULL
at	NULL
4°C	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
*°P	NULL
end-labeled	NULL
probe	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Anti-c-fos	NULL
and	NULL
anti-c-jun	NULL
inhibited	NULL
DNA-protein	NULL
complex	NULL
formation	NULL
.	NULL

A	NULL
role	NULL
for	NULL
the	NULL
MAPK	NULL
cascade	NULL
in	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
regulation	NULL
.	NULL

The	NULL
signaling	NULL
cascades	NULL
that	NULL
lead	NULL
to	NULL
API	NULL
activation	NULL
include	NULL
numerous	NULL
mitogen	NULL
activated	NULL
protein	NULL
kinase	NULL
intermediates	NULL
and	NULL
transcriptional	NULL
induction	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
Recent	NULL
observations	NULL
showed	NULL
that	NULL
inhibition	NULL
of	NULL
MAPK	NULL
kinase	NULL
1	NULL
(	NULL
MAPKK1	NULL
)	NULL
prevented	NULL
some	NULL
features	NULL
of	NULL
phorbol-induced	NULL
megakaryocytic	NULL
differentiation	NULL
,	NULL
including	NULL
expression	NULL
of	NULL
the	NULL
op	NULL
,	NULL
and	NULL
B	NULL
;	NULL
integrin	NULL
genes	NULL
.	NULL
``	NULL

The	NULL
role	NULL
of	NULL
MAPKK1	NULL
in	NULL
regulating	NULL
o	NULL
integrin	NULL
gene	NULL
expression	NULL
was	NULL
therefore	NULL
evaluated	NULL
.	NULL

As	NULL
shown	NULL
previously	NULL
,	NULL
uninduced	NULL
K562	NULL
cells	NULL
fail	NULL
to	NULL
express	NULL
detectable	NULL
levels	NULL
of	NULL
the	NULL
«	NULL
,	NULL
B	NULL
;	NULL
integrin	NULL
(	NULL
Fig	NULL
9	NULL
)	NULL
.	NULL

After	NULL
6	NULL
days	NULL
of	NULL
PDB	NULL
induction	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
«	NULL
;	NULL
f	NULL
;	NULL
integrin	NULL
is	NULL
greatly	NULL
increased	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
PD98059	NULL
,	NULL
the	NULL
MAPKK	NULL
1	NULL
specific	NULL
inhibitor	NULL
,	NULL
to	NULL
K562	NULL
cells	NULL
15	NULL
minutes	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
PDB	NULL
completely	NULL
eliminated	NULL
«	NULL
,	NULL
B	NULL
;	NULL
integrin	NULL
subunit	NULL
expression	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
9	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
MAPK	NULL
cascade	NULL
in	NULL
activating	NULL
the	NULL
«	NULL
,	NULL
promoter/	NULL
enhancer	NULL
was	NULL
assessed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figs	NULL
2B	NULL
and	NULL
10	NULL
,	NULL
the	NULL
reporter	NULL
gene	NULL
activity	NULL
of	NULL
the	NULL
original	NULL
intact	NULL
a	NULL
integrin	NULL
promoter/	NULL
enhancer	NULL
construct	NULL
po	NULL
;	NULL
2592-CAT	NULL
was	NULL
high	NULL
in	NULL
induced	NULL
K562	NULL
cells	NULL
and	NULL
at	NULL
background	NULL
levels	NULL
in	NULL
uninduced	NULL
K562	NULL
.	NULL

Reporter	NULL
gene	NULL
activity	NULL
of	NULL
the	NULL
pa,2592-CAT	NULL
in	NULL
K562	NULL
cells	NULL
treated	NULL
with	NULL
both	NULL
PDB	NULL
and	NULL
PD98059	NULL
was	NULL
markedly	NULL
reduced	NULL
compared	NULL
with	NULL
the	NULL
reporter	NULL
activity	NULL
in	NULL
PDB	NULL
induced	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
10	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
the	NULL
MAPK	NULL
kinase	NULL
cascade	NULL
diminished	NULL
the	NULL
function	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
promoter/enhancer	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
findings	NULL
,	NULL
1607	NULL
we	NULL
propose	NULL
a	NULL
model	NULL
by	NULL
which	NULL
activation	NULL
of	NULL
the	NULL
MAPK	NULL
cascade	NULL
leads	NULL
to	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
induced	NULL
to	NULL
become	NULL
megakaryocytic	NULL
(	NULL
Fig	NULL
11	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
earlier	NULL
studies	NULL
we	NULL
demonstrated	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
in	NULL
cells	NULL
with	NULL
megakaryocytic	NULL
features	NULL
,	NULL
both	NULL
induced	NULL
K562	NULL
cells	NULL
and	NULL
DAMI	NULL
cells	NULL
,	NULL
is	NULL
regulated	NULL
by	NULL
three	NULL
distinct	NULL
regions	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flank	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
containing	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
elements	NULL
.	NULL

'*	NULL
The	NULL
three	NULL
regions	NULL
include	NULL
a	NULL
core	NULL
promoter	NULL
between	NULL
bp	NULL
-30	NULL
and	NULL
-92	NULL
,	NULL
a	NULL
silencer	NULL
between	NULL
bp	NULL
-92	NULL
and	NULL
-351	NULL
,	NULL
and	NULL
megakaryocytic	NULL
enhancers	NULL
between	NULL
bp	NULL
-1426	NULL
and	NULL
-2592	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
using	NULL
a	NULL
combination	NULL
of	NULL
deletional	NULL
and	NULL
mutational	NULL
analyses	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
megakaryocytic	NULL
enhancer	NULL
of	NULL
the	NULL
a	NULL
,	NULL
integrin	NULL
gene	NULL
.	NULL

The	NULL
enhancer	NULL
requires	NULL
two	NULL
tandem	NULL
inversely	NULL
oriented	NULL
AP1	NULL
consensus	NULL
binding	NULL
sites	NULL
for	NULL
interaction	NULL
with	NULL
c-fos/c-jun	NULL
family	NULL
members	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
a	NULL
model	NULL
in	NULL
which	NULL
signaling	NULL
via	NULL
the	NULL
MAPK	NULL
cascade	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
megakaryocytic	NULL
enhancer	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
(	NULL
Fig	NULL
11	NULL
)	NULL
.	NULL

Extracellular	NULL
stimuli	NULL
such	NULL
as	NULL
phorbol	NULL
dibutyrate	NULL
under	NULL
our	NULL
experimental	NULL
conditions	NULL
or	NULL
growth	NULL
factors	NULL
during	NULL
thrombopoiesis	NULL
directly	NULL
or	NULL
indirectly	NULL
activate	NULL
the	NULL
MAPK	NULL
signaling	NULL
cascade	NULL
.	NULL

The	NULL
MAP	NULL
kinase	NULL
cascade	NULL
involves	NULL
at	NULL
least	NULL
three	NULL
distinct	NULL
signaling	NULL
pathways	NULL
,	NULL
including	NULL
the	NULL
extracellular	NULL
regulated	NULL
ki-nases	NULL
(	NULL
ERK	NULL
)	NULL
,	NULL
jun	NULL
kinase	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
.	NULL

The	NULL
best	NULL
delineated	NULL
pathway	NULL
initiated	NULL
via	NULL
growth	NULL
factor	NULL
receptors	NULL
or	NULL
phorbol	NULL
esters	NULL
initiates	NULL
a	NULL
cascade	NULL
from	NULL
ras	NULL
,	NULL
raf	NULL
,	NULL
MAPKK1	NULL
(	NULL
MEK1	NULL
)	NULL
,	NULL
or	NULL
MAPKK2	NULL
(	NULL
MEK	NULL
?	NULL
)	NULL

to	NULL
ERK	NULL
1	NULL
or	NULL
ERK2.3°*	NULL
'	NULL
The	NULL
activated	NULL
ERK	NULL
proteins	NULL
then	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
to	NULL
phosphorylate	NULL
and	NULL
activate	NULL
nuclear	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
ternary	NULL
complex	NULL
factors	NULL
(	NULL
TCF	NULL
)	NULL
.42	NULL
ERK	NULL
activation	NULL
directly	NULL
increases	NULL
AP1	NULL
activity	NULL
via	NULL
c-jun	NULL
activation	NULL
and	NULL
increased	NULL
c-fos	NULL
synthesis	NULL
,	NULL
leading	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
c-fos/c-jun	NULL
heterodimerization	NULL
and	NULL
DNA	NULL
binding	NULL
.	NULL
``	NULL

A	NULL
role	NULL
for	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
in	NULL
megakaryocytic	NULL
differentiation	NULL
was	NULL
originally	NULL
suggested	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
phorbol	NULL
esters	NULL
to	NULL
initiate	NULL
megakaryocytic	NULL
differentiation	NULL
and	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
megakaryocyte-specific	NULL
genes	NULL
.	NULL
'	NULL

''	NULL
``	NULL
'	NULL
A	NULL
direct	NULL
role	NULL
for	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
in	NULL
megakaryocytic	NULL
differentiation	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
a	NULL
number	NULL
of	NULL
investigators	NULL
.	NULL

``	NULL
*	NULL
414445	NULL
Megakaryocytic	NULL
differentiation	NULL
of	NULL
K562	NULL
cells	NULL
induced	NULL
with	NULL
phorbol	NULL
dibutyrate	NULL
,	NULL
including	NULL
the	NULL
morphologic	NULL
aspects	NULL
of	NULL
cell	NULL
adhesion	NULL
and	NULL
cell	NULL
spreading	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
megakaryocytic	NULL
genes	NULL
encoding	NULL
the	NULL
app	NULL
and	NULL
B	NULL
;	NULL
integrin	NULL
sub-units	NULL
,	NULL
was	NULL
either	NULL
partially	NULL
or	NULL
completely	NULL
inhibited	NULL
by	NULL
PD98059	NULL
,	NULL
the	NULL
MAPKK	NULL
1	NULL
specific	NULL
inhibitor	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
constitutive	NULL
activation	NULL
of	NULL
the	NULL
pathway	NULL
via	NULL
expression	NULL
of	NULL
the	NULL
constitutively	NULL
active	NULL
mutants	NULL
of	NULL
MAPKK1	NULL
or	NULL
MAPKK2	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
platelet/megakaryocytic-specific	NULL
genes	NULL
op	NULL
,	NULL
and	NULL
B3	NULL
.	NULL

The	NULL
regulatory	NULL
elements	NULL
required	NULL
for	NULL
expression	NULL
of	NULL
megakaryocyte-specific	NULL
proteins	NULL
oup	NULL
,	NULL
B3	NULL
,	NULL
platelet	NULL
factor	NULL
4	NULL
(	NULL
PF4	NULL
)	NULL
,	NULL
glycoprotein	NULL
Ib	NULL
,	NULL
and	NULL
c-mpl	NULL
have	NULL
been	NULL
mapped	NULL
.	NULL
``	NULL

Adjacent	NULL
GATA	NULL
and	NULL
ets	NULL
consensus	NULL
binding	NULL
sites	NULL
identified	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
app	NULL
,	NULL
PF4	NULL
,	NULL
glycoprotein	NULL
Ib	NULL
,	NULL
and	NULL
c-mpl	NULL
are	NULL
essential	NULL
for	NULL
transcriptional	NULL
activation	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

``	NULL
``	NULL
28458	NULL
GATA	NULL
and	NULL
ets	NULL
transcription	NULL
factors	NULL
are	NULL
activated	NULL
by	NULL
the	NULL
MAPK	NULL
cascade	NULL
.	NULL

The	NULL
important	NULL
role	NULL
that	NULL
adjacent	NULL
GATA	NULL
and	NULL
ets	NULL
binding	NULL
sites	NULL
play	NULL
in	NULL
activation	NULL
of	NULL
many	NULL
megakaryocyte-specific	NULL
genes	NULL
led	NULL
us	NULL
to	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
the	NULL
adjacent	NULL
GATA	NULL
and	NULL
AP2	NULL
sites	NULL
in	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1608	NULL
1007	NULL
UNINDUCED	NULL
CC	NULL
L	NULL
--	NULL
--	NULL
=	NULL
Control	NULL
2	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
=	NULL
c	NULL
By	NULL
aa	NULL
)	NULL
2	NULL
=	NULL
.	NULL

«	NULL
-l	NULL
ad	NULL
LW	NULL
(	NULL
&	NULL
]	NULL
0	NULL
T	NULL
--	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
10°	NULL
10	NULL
10	NULL
10°	NULL
104	NULL
1007	NULL
6	NULL
DAY	NULL
IND	NULL
.	NULL

CC	NULL
LU	NULL
m	NULL
=	NULL
jam	NULL
]	NULL
z	NULL
wd	NULL
ad	NULL
LLU	NULL
[	NULL
®	NULL
]	NULL
0	NULL
0	NULL
1007	NULL
PD98059	NULL
+	NULL
6	NULL
DAY	NULL
IND	NULL
.	NULL

CC	NULL
LLU	NULL
o	NULL
3	NULL
5	NULL
_	NULL
ae	NULL
.	NULL

mad	NULL
wal	NULL
LW	NULL
[	NULL
®	NULL
]	NULL
0	NULL
#	NULL
0	NULL
110°	NULL
10	NULL
``	NULL
1:12	NULL
163	NULL
HI	NULL
)	NULL
“	NULL
FLUORESCENCE	NULL
INTENSITY	NULL
Fig	NULL
9	NULL
.	NULL

Inhibition	NULL
of	NULL
«	NULL
)	NULL
B	NULL
,	NULL
integrin	NULL
expression	NULL
by	NULL
PD98059	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
the	NULL
«	NULL
,	NULL
B	NULL
,	NULL
integrin	NULL
expression	NULL
by	NULL
uninduced	NULL
K562	NULL
cells	NULL
,	NULL
K562	NULL
cells	NULL
induced	NULL
for	NULL
6	NULL
days	NULL
with	NULL
PDB	NULL
(	NULL
40	NULL
nmol/L	NULL
)	NULL
(	NULL
6d	NULL
Ind	NULL
)	NULL
,	NULL
or	NULL
K562	NULL
cells	NULL
treated	NULL
with	NULL
PD98059	NULL
(	NULL
50	NULL
pmol/L	NULL
)	NULL
for	NULL
15	NULL
minutes	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
PDB	NULL
(	NULL
40	NULL
nmol/L	NULL
)	NULL
(	NULL
PD98059	NULL
+	NULL
6d	NULL
Ind	NULL
)	NULL
.	NULL

ZUTTER	NULL
,	NULL
PAINTER	NULL
,	NULL
AND	NULL
YANG	NULL
125	NULL
100	NULL
~	NULL
&	NULL
n	NULL
1	NULL
Relative	NULL
CAT	NULL
Activity	NULL
8	NULL
ho	NULL
dn	NULL
1	NULL
I	NULL
}	NULL
pCAT-Basic	NULL
pe	NULL
2	NULL
2592-CAT	NULL
Fig	NULL
10	NULL
.	NULL

Diminution	NULL
of	NULL
«	NULL
,	NULL
promoter/	NULL
enhancer	NULL
function	NULL
by	NULL
PD98059	NULL
.	NULL

The	NULL
constructs	NULL
pCAT-Basic	NULL
and	NULL
pa	NULL
;	NULL
2592-CAT	NULL
were	NULL
transfected	NULL
into	NULL
uninduced	NULL
K562	NULL
cells	NULL
(	NULL
C	NULL
)	NULL
)	NULL
,	NULL
K562	NULL
cells	NULL
treated	NULL
with	NULL
PDB	NULL
(	NULL
40	NULL
nmol/	NULL
L	NULL
;	NULL
MM	NULL
)	NULL
,	NULL
and	NULL
K562	NULL
cells	NULL
treated	NULL
for	NULL
15	NULL
minutes	NULL
with	NULL
PD98059	NULL
(	NULL
50	NULL
pmol/L	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
PDB	NULL
(	NULL
40	NULL
nmol/L	NULL
;	NULL
[	NULL
X	NULL
)	NULL
.	NULL

Cotransfection	NULL
with	NULL
RSV-luciferase	NULL
was	NULL
used	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

After	NULL
48	NULL
hours	NULL
of	NULL
incubation	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
assayed	NULL
.	NULL

After	NULL
normalization	NULL
for	NULL
transfection	NULL
efficiency	NULL
,	NULL
CAT	NULL
activity	NULL
of	NULL
the	NULL
constructs	NULL
was	NULL
determined	NULL
using	NULL
thin-layer	NULL
chromatography	NULL
.	NULL

The	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
uninduced	NULL
K562	NULL
cells	NULL
,	NULL
PDB-induced	NULL
K562	NULL
cells	NULL
,	NULL
or	NULL
K562	NULL
cells	NULL
treated	NULL
with	NULL
PD98059	NULL
and	NULL
PDB	NULL
was	NULL
determined	NULL
.	NULL

CAT	NULL
activity	NULL
relative	NULL
to	NULL
the	NULL
pCAT-Basic	NULL
construct	NULL
in	NULL
uninduced	NULL
K562	NULL
,	NULL
which	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1.0	NULL
,	NULL
is	NULL
shown	NULL
.	NULL

enhancer	NULL
activity	NULL
of	NULL
the	NULL
a	NULL
,	NULL
integrin	NULL
gene	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
GATA	NULL
and	NULL
AP2	NULL
sites	NULL
did	NULL
not	NULL
serve	NULL
enhancer	NULL
function	NULL
and	NULL
served	NULL
to	NULL
slightly	NULL
repress	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
of	NULL
the	NULL
o	NULL
>	NULL
integrin	NULL
gene	NULL
.	NULL

Although	NULL
the	NULL
architecture	NULL
of	NULL
the	NULL
a	NULL
,	NULL
promoter/	NULL
enhancer	NULL
that	NULL
consists	NULL
of	NULL
a	NULL
promoter	NULL
,	NULL
a	NULL
silencer	NULL
,	NULL
and	NULL
a	NULL
distal	NULL
enhancer	NULL
resembles	NULL
other	NULL
megakaryocytic	NULL
genes	NULL
,	NULL
the	NULL
enhancer	NULL
is	NULL
distinctly	NULL
different	NULL
and	NULL
consists	NULL
of	NULL
two	NULL
adjacent	NULL
but	NULL
inversely	NULL
oriented	NULL
AP1	NULL
binding	NULL
sites	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
or	NULL
both	NULL
AP1	NULL
sites	NULL
markedly	NULL
reduced	NULL
enhancer	NULL
activity	NULL
in	NULL
the	NULL
irrelevant	NULL
promoter	NULL
construct	NULL
SV40pCAT	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
intact	NULL
a	NULL
;	NULL
promoter/enhancer	NULL
construct	NULL
extending	NULL
through	NULL
the	NULL
distal	NULL
5	NULL
'	NULL
flank	NULL
of	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
.	NULL

Consensus	NULL
API	NULL
binding	NULL
sites	NULL
have	NULL
not	NULL
been	NULL
demonstrated	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
enhancer	NULL
activity	NULL
of	NULL
other	NULL
megakaryocytic	NULL
genes	NULL
.	NULL

However	NULL
,	NULL
the	NULL
inverse	NULL
orientation	NULL
of	NULL
the	NULL
two	NULL
API	NULL
sites	NULL
resembles	NULL
the	NULL
dyad	NULL
symmetry	NULL
element	NULL
(	NULL
DSE	NULL
)	NULL
required	NULL
for	NULL
c-fos	NULL
induction	NULL
after	NULL
12-0-tetradecanoyl	NULL
phorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
-induced	NULL
megakaryocytic	NULL
differentiation	NULL
of	NULL
K562	NULL
cells	NULL
.	NULL
``	NULL

AP1	NULL
,	NULL
a	NULL
sequence-specific	NULL
transcription	NULL
factor	NULL
composed	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
family	NULL
members	NULL
,	NULL
was	NULL
initially	NULL
identified	NULL
as	NULL
the	NULL
factor	NULL
that	NULL
mediates	NULL
TPA	NULL
Activation	NULL
and	NULL
expression	NULL
of	NULL
AP1	NULL
is	NULL
induced	NULL
by	NULL
multiple	NULL
stimuli	NULL
,	NULL
including	NULL
growth	NULL
factors	NULL
,	NULL
cytokines	NULL
,	NULL
UV	NULL
irradiation	NULL
,	NULL
and	NULL
the	NULL
different	NULL
members	NULL
of	NULL
the	NULL
MAPK	NULL
The	NULL
NF-E2	NULL
binding	NULL
site	NULL
consists	NULL
of	NULL
either	NULL
one	NULL
or	NULL
tandem	NULL
,	NULL
extended	NULL
AP1	NULL
binding	NULL
sites	NULL
.	NULL

``	NULL
``	NULL
~*	NULL
A	NULL
possible	NULL
role	NULL
for	NULL
NF-E2	NULL
in	NULL
a	NULL
integrin	NULL
gene	NULL
regulation	NULL
was	NULL
considered	NULL
.	NULL

``	NULL
``	NULL
~	NULL
``	NULL
The	NULL
NF-E2	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
hypersensitivity	NULL
site	NULL
2	NULL
(	NULL
HS2	NULL
)	NULL
enhancer	NULL
of	NULL
the	NULL
B	NULL
globin	NULL
gene	NULL
resemble	NULL
the	NULL
two	NULL
tandem	NULL
API	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MEGAKARYOCYTE	NULL
ENHANCER	NULL
OF	NULL
THE	NULL
a	NULL
;	NULL
B	NULL
,	NULL
INTEGRIN	NULL
GENE	NULL
1609	NULL
Growth	NULL
factors	NULL
and	NULL
PDB	NULL
Cn	NULL
MAPE	NULL
‘	NULL
K	NULL
ERK	NULL
I	NULL
Jun	NULL
kinase	NULL
4	NULL
``	NULL
y/	NULL
1	NULL
1	NULL
f	NULL
1	NULL
I	NULL
ATH	NULL
c-jun	NULL
c-fos	NULL
I	NULL
I	NULL
i	NULL
I	NULL
I	NULL
1	NULL
¥	NULL
¥	NULL
|	NULL
$	NULL
Alpha	NULL
2	NULL
enhancer	NULL
Alpha	NULL
2	NULL
integrin	NULL
gene	NULL
Fig	NULL
11	NULL
.	NULL

A	NULL
proposed	NULL
pathway	NULL
for	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
«	NULL
;	NULL
integrin	NULL
subunit	NULL
in	NULL
cells	NULL
with	NULL
megakaryocytic	NULL
features	NULL
.	NULL

Both	NULL
growth	NULL
factors	NULL
and	NULL
PDB	NULL
indirectly	NULL
activate	NULL
the	NULL
MAPK	NULL
cascade	NULL
,	NULL
including	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
(	NULL
MAPKK	NULL
)	NULL
,	NULL
extracellular	NULL
receptor	NULL
activated	NULL
kinase	NULL
(	NULL
Erk	NULL
)	NULL
,	NULL
and	NULL
Jun	NULL
kinase	NULL
via	NULL
intermediate	NULL
signaling	NULL
molecules	NULL
,	NULL
including	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
.	NULL

Activated	NULL
Erk	NULL
and	NULL
Jun	NULL
kinase	NULL
increase	NULL
c-fos	NULL
and	NULL
c-jun	NULL
synthesis	NULL
by	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
complex	NULL
factors	NULL
(	NULL
TCF	NULL
)	NULL
,	NULL
serum	NULL
response	NULL
factors	NULL
(	NULL
SRF	NULL
)	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
activating	NULL
transcription	NULL
factors	NULL
(	NULL
ATF	NULL
)	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
Erk	NULL
and	NULL
Jun	NULL
kinase	NULL
phosphorylation	NULL
augment	NULL
the	NULL
activity	NULL
of	NULL
both	NULL
c-fos	NULL
and	NULL
c-jun	NULL
.	NULL

New	NULL
ly	NULL
synthesized	NULL
(	NULL
-	NULL
)	NULL
and	NULL
phosphorylated	NULL
(	NULL
--	NULL
-	NULL
)	NULL
c-fos	NULL
and	NULL
c-jun	NULL
family	NULL
members	NULL
heterodimerize	NULL
to	NULL
bind	NULL
the	NULL
tandem	NULL
and	NULL
inversely	NULL
oriented	NULL
AP1	NULL
binding	NULL
sites	NULL
of	NULL
the	NULL
«	NULL
,	NULL
integrin	NULL
enhancer	NULL
and	NULL
upregulate	NULL
«	NULL
;	NULL
integrin	NULL
gene	NULL
expression	NULL
.	NULL

a	NULL
,	NULL
integrin	NULL
enhancer	NULL
.	NULL

``	NULL
*	NULL
``	NULL
°	NULL
However	NULL
,	NULL
the	NULL
additional	NULL
-G-	NULL
in	NULL
the	NULL
GCTGAGTC	NULL
sequence	NULL
that	NULL
is	NULL
required	NULL
for	NULL
NF-E2	NULL
binding	NULL
is	NULL
absent	NULL
from	NULL
both	NULL
of	NULL
the	NULL
tandem	NULL
API	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
o	NULL
,	NULL
integrin	NULL
enhancer	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
although	NULL
nuclear	NULL
proteins	NULL
from	NULL
induced	NULL
K562	NULL
cells	NULL
bind	NULL
to	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
NF-E2	NULL
binding	NULL
site	NULL
and	NULL
the	NULL
unlabeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-E2	NULL
consensus	NULL
binding	NULL
site	NULL
successfully	NULL
inhibits	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
NF-E2	NULL
,	NULL
the	NULL
unlabeled	NULL
NF-E2	NULL
oligonucleotide	NULL
fails	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
megakaryocyte	NULL
enhancer	NULL
region	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
hematopoietic	NULL
restricted	NULL
component	NULL
p45	NULL
failed	NULL
to	NULL
induce	NULL
megakaryocytic	NULL
differentiation	NULL
or	NULL
expression	NULL
of	NULL
the	NULL
o	NULL
;	NULL
B	NULL
,	NULL
integrin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
studies	NULL
presented	NULL
here	NULL
,	NULL
the	NULL
MAPK	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
«	NULL
,	NULL
integrin	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
induced	NULL
to	NULL
differentiate	NULL
along	NULL
the	NULL
megakaryocytic	NULL
lineage	NULL
.	NULL

Two	NULL
tandem	NULL
and	NULL
inversely	NULL
oriented	NULL
API	NULL
sites	NULL
in	NULL
the	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
enhancer	NULL
bind	NULL
to	NULL
members	NULL
of	NULL
the	NULL
AP1	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

We	NULL
propose	NULL
a	NULL
model	NULL
by	NULL
which	NULL
either	NULL
PDB	NULL
,	NULL
under	NULL
experimental	NULL
conditions	NULL
,	NULL
or	NULL
growth	NULL
factors	NULL
such	NULL
as	NULL
thrombopoietin	NULL
(	NULL
TPO	NULL
)	NULL
,	NULL
under	NULL
physiologic	NULL
conditions	NULL
,	NULL
activate	NULL
the	NULL
MAPK	NULL
cascade	NULL
and	NULL
ultimately	NULL
lead	NULL
to	NULL
a	NULL
,	NULL
integrin	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
induced	NULL
to	NULL
be	NULL
megakaryocytic	NULL
.	NULL

The	NULL
mechanisms	NULL
by	NULL
which	NULL
PDB	NULL
activates	NULL
c-fos/c-jun	NULL
family	NULL
members	NULL
is	NULL
well	NULL
delineated	NULL
.	NULL
``	NULL

}	NULL
TPO	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
directly	NULL
activate	NULL
the	NULL
MAPK	NULL
cascade	NULL
after	NULL
binding	NULL
to	NULL
c-Mpl	NULL
on	NULL
megakaryocytic	NULL
This	NULL
model	NULL
provides	NULL
a	NULL
physiologically	NULL
relevant	NULL
series	NULL
of	NULL
events	NULL
that	NULL
lead	NULL
to	NULL
expression	NULL
of	NULL
the	NULL
oB	NULL
;	NULL
integrin	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
Dr	NULL
Samuel	NULL
A.	NULL
Santoro	NULL
for	NULL
encouragement	NULL
and	NULL
constructive	NULL
criticism	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Mary	NULL
Beth	NULL
Flynn	NULL
for	NULL
excellent	NULL
secretarial	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Giancotti	NULL
F	NULL
,	NULL
Comoglio	NULL
PM	NULL
,	NULL
Tarone	NULL
G	NULL
:	NULL
Fibronectin-plasma	NULL
membrane	NULL
interaction	NULL
in	NULL
the	NULL
adhesion	NULL
of	NULL
hemopoietic	NULL
cells	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
103:429	NULL
,	NULL
1986	NULL
2	NULL
.	NULL

Tsai	NULL
S	NULL
,	NULL
Patel	NULL
V	NULL
,	NULL
Beaumont	NULL
E	NULL
,	NULL
Lodish	NULL
H	NULL
,	NULL
Nathan	NULL
D	NULL
,	NULL
Sieff	NULL
C	NULL
:	NULL
Differential	NULL
binding	NULL
of	NULL
erythroid	NULL
and	NULL
myeloid	NULL
progenitors	NULL
to	NULL
fibroblasts	NULL
and	NULL
fibronectin	NULL
.	NULL

Blood	NULL
6:1587	NULL
,	NULL
1987	NULL
3	NULL
.	NULL

Santoro	NULL
SA	NULL
:	NULL
Platelet	NULL
membrane	NULL
:	NULL
Receptors	NULL
,	NULL
in	NULL
Jamieson	NULL
GA	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1610	NULL
Molecular	NULL
Biology	NULL
,	NULL
Immunology	NULL
,	NULL
Biochemistry	NULL
and	NULL
Pathology	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Liss	NULL
,	NULL
1988	NULL
,	NULL
p	NULL
291	NULL
4	NULL
.	NULL

Nieuwenhuis	NULL
HK	NULL
,	NULL
Akkerman	NULL
JWN	NULL
,	NULL
Houdijk	NULL
WPM	NULL
,	NULL
Sixma	NULL
JJ	NULL
:	NULL
Human	NULL
blood	NULL
platelets	NULL
showing	NULL
no	NULL
response	NULL
to	NULL
collagen	NULL
fail	NULL
to	NULL
express	NULL
surface	NULL
glycoprotein	NULL
Ia	NULL
.	NULL

Nature	NULL
318:470	NULL
,	NULL
1985	NULL
5	NULL
.	NULL

Nieuwenhuis	NULL
HK	NULL
,	NULL
Sakariassen	NULL
KS	NULL
,	NULL
Houdijk	NULL
WPM	NULL
,	NULL
Nievelstein	NULL
PFEM	NULL
,	NULL
Sixma	NULL
JJ	NULL
:	NULL
Deficiency	NULL
of	NULL
platelet	NULL
membrane	NULL
glycoprotein	NULL
Ta	NULL
associated	NULL
with	NULL
a	NULL
decreased	NULL
platelet	NULL
adhesion	NULL
to	NULL
subendothelium	NULL
:	NULL
A	NULL
defect	NULL
in	NULL
platelet	NULL
spreading	NULL
.	NULL

Blood	NULL
68:692	NULL
,	NULL
1986	NULL
6	NULL
.	NULL

Saelman	NULL
EU	NULL
,	NULL
Kehrel	NULL
B	NULL
,	NULL
Hese	NULL
KM	NULL
,	NULL
de	NULL
Groot	NULL
PG	NULL
,	NULL
Sixma	NULL
JJ	NULL
,	NULL
Nieuwenhuis	NULL
HK	NULL
:	NULL
Platelet	NULL
adhesion	NULL
to	NULL
collagen	NULL
and	NULL
endothelial	NULL
cell	NULL
matrix	NULL
under	NULL
flow	NULL
conditions	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
platelet	NULL
glycoprotein	NULL
IV	NULL
.	NULL

Blood	NULL
83:3240	NULL
,	NULL
1994	NULL
7	NULL
.	NULL

Saelman	NULL
EU	NULL
,	NULL
Nieuwenhuis	NULL
HK	NULL
,	NULL
Hese	NULL
KM	NULL
,	NULL
de	NULL
Groot	NULL
PG	NULL
,	NULL
Heijnen	NULL
HF	NULL
,	NULL
Sage	NULL
EH	NULL
,	NULL
Williams	NULL
S	NULL
,	NULL
McKeown	NULL
L	NULL
,	NULL
Gralnick	NULL
HR	NULL
,	NULL
Sixma	NULL
JJ	NULL
:	NULL
Platelet	NULL
adhesion	NULL
to	NULL
collagen	NULL
types	NULL
I	NULL
through	NULL
VIII	NULL
under	NULL
conditions	NULL
of	NULL
stasis	NULL
and	NULL
flow	NULL
is	NULL
mediated	NULL
by	NULL
GPIa/Ha	NULL
(	NULL
alpha	NULL
2	NULL
beta	NULL
1-integrin	NULL
)	NULL
.	NULL

Blood	NULL
83:1244	NULL
,	NULL
1994	NULL
8	NULL
.	NULL

Kehrel	NULL
B	NULL
,	NULL
Balleisen	NULL
L	NULL
,	NULL
Kokott	NULL
R	NULL
,	NULL
Mesters	NULL
R	NULL
,	NULL
Stenzinger	NULL
W	NULL
,	NULL
Clemetson	NULL
KJ	NULL
,	NULL
Van	NULL
de	NULL
Loo	NULL
J	NULL
:	NULL
Deficiency	NULL
of	NULL
intact	NULL
thrombospondin	NULL
and	NULL
membrane	NULL
glycoprotein	NULL
Ia	NULL
in	NULL
platelets	NULL
with	NULL
defective	NULL
collagen-induced	NULL
aggregation	NULL
and	NULL
spontaneous	NULL
loss	NULL
of	NULL
disorder	NULL
.	NULL

Blood	NULL
71:1074	NULL
,	NULL
1988	NULL
9	NULL
.	NULL

Handa	NULL
M	NULL
,	NULL
Watanabe	NULL
K	NULL
,	NULL
Kawai	NULL
Y	NULL
,	NULL
Kamata	NULL
T	NULL
,	NULL
Koyama	NULL
T	NULL
,	NULL
Nagai	NULL
H	NULL
,	NULL
Ikeda	NULL
Y	NULL
:	NULL
Platelet	NULL
unresponsiveness	NULL
to	NULL
collagen	NULL
:	NULL
Involvement	NULL
of	NULL
glycoprotein	NULL
Ta-Ia	NULL
(	NULL
a	NULL
;	NULL
B	NULL
;	NULL
integrin	NULL
)	NULL
deficiency	NULL
associated	NULL
with	NULL
a	NULL
myeloprolif-erative	NULL
disorder	NULL
.	NULL

Thromb	NULL
Haemost	NULL
73:521	NULL
,	NULL
1995	NULL
10	NULL
.	NULL

Burger	NULL
SR	NULL
,	NULL
Zuttee	NULL
MM	NULL
,	NULL
Sturgill-Koszycki	NULL
S	NULL
,	NULL
Santoro	NULL
SA	NULL
:	NULL
Increased	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
functional	NULL
«	NULL
;	NULL
f	NULL
,	NULL
integrin	NULL
accompanies	NULL
the	NULL
megakaryocytic	NULL
differentiation	NULL
of	NULL
K562	NULL
leukemia	NULL
cells	NULL
.	NULL

Exp	NULL
Cell	NULL
Res	NULL
202:28	NULL
,	NULL
1992	NULL
11	NULL
.	NULL

Zutter	NULL
MM	NULL
,	NULL
Fong	NULL
AM	NULL
,	NULL
Krigman	NULL
HR	NULL
,	NULL
Santoro	NULL
SA	NULL
:	NULL
Differential	NULL
regulation	NULL
of	NULL
the	NULL
a	NULL
;	NULL
B	NULL
;	NULL
and	NULL
appB	NULL
;	NULL
integrin	NULL
genes	NULL
during	NULL
megakaryocytic	NULL
differentiation	NULL
of	NULL
pluripotent	NULL
K562	NULL
leukemia	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:20233	NULL
,	NULL
1992	NULL
12	NULL
.	NULL

Zutter	NULL
MM	NULL
,	NULL
Santoro	NULL
SA	NULL
:	NULL
Widespread	NULL
histologic	NULL
distribution	NULL
of	NULL
the	NULL
a	NULL
;	NULL
B	NULL
;	NULL
integrin	NULL
cell-surface	NULL
collagen	NULL
receptor	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
137:113	NULL
,	NULL
1990	NULL
13	NULL
.	NULL

Zutter	NULL
MM	NULL
,	NULL
Santoro	NULL
SA	NULL
,	NULL
Painter	NULL
AS	NULL
,	NULL
Tsung	NULL
YL	NULL
,	NULL
Gafford	NULL
A	NULL
:	NULL
The	NULL
human	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
promoter	NULL
:	NULL
Identification	NULL
of	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
elements	NULL
important	NULL
for	NULL
cell-type	NULL
and	NULL
developmen-tally-restricted	NULL
gene	NULL
expression	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:463	NULL
,	NULL
1994	NULL
14	NULL
.	NULL

Zutter	NULL
MM	NULL
,	NULL
Painter	NULL
AD	NULL
,	NULL
Staatz	NULL
WD	NULL
,	NULL
Tsung	NULL
YL	NULL
:	NULL
Regulation	NULL
of	NULL
a	NULL
;	NULL
integrin	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
with	NULL
megakaryocytic	NULL
features	NULL
:	NULL
A	NULL
common	NULL
theme	NULL
of	NULL
three	NULL
necessary	NULL
elements	NULL
.	NULL

Blood	NULL
86:3006	NULL
,	NULL
1995	NULL
15	NULL
.	NULL

Xu	NULL
J	NULL
,	NULL
Zuttee	NULL
MM	NULL
,	NULL
Santoro	NULL
SA	NULL
,	NULL
Clark	NULL
RAF	NULL
:	NULL
A	NULL
three-dimensional	NULL
collagen	NULL
lattice	NULL
activates	NULL
in	NULL
human	NULL
fibroblasts	NULL
:	NULL
Role	NULL
in	NULL
integrin	NULL
«	NULL
gene	NULL
expression	NULL
and	NULL
tissue	NULL
remodeling	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
140:709	NULL
,	NULL
1998	NULL
16	NULL
.	NULL

Zuttee	NULL
MM	NULL
,	NULL
Ryan	NULL
EE	NULL
,	NULL
Painter	NULL
AD	NULL
:	NULL
Binding	NULL
of	NULL
phosphorylated	NULL
Sp1	NULL
protein	NULL
to	NULL
tandem	NULL
Sp1	NULL
binding	NULL
sites	NULL
regulates	NULL
a	NULL
integrin	NULL
gene	NULL
core	NULL
promoter	NULL
activity	NULL
.	NULL

Blood	NULL
90:678	NULL
,	NULL
1997	NULL
17	NULL
.	NULL

Ulrich	NULL
MJ	NULL
,	NULL
Ley	NULL
TJ	NULL
:	NULL
Function	NULL
of	NULL
normal	NULL
and	NULL
mutated	NULL
gamma	NULL
globin	NULL
gene	NULL
promoters	NULL
in	NULL
electroporated	NULL
K562	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Blood	NULL
75:990	NULL
,	NULL
1990	NULL
18	NULL
.	NULL

Nguyen	NULL
VT	NULL
,	NULL
Morange	NULL
M	NULL
,	NULL
Bensaude	NULL
O	NULL
:	NULL
Firefly	NULL
luciferase	NULL
luminescence	NULL
assays	NULL
using	NULL
scintillation	NULL
counters	NULL
for	NULL
quantitation	NULL
in	NULL
transfected	NULL
mammalian	NULL
cells	NULL
.	NULL

Anal	NULL
Biochem	NULL
171:404	NULL
,	NULL
1988	NULL
19	NULL
.	NULL

Gorman	NULL
CM	NULL
,	NULL
Moffat	NULL
LF	NULL
,	NULL
Howard	NULL
BH	NULL
:	NULL
Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
2:1044	NULL
,	NULL
1982	NULL
20	NULL
.	NULL

Fong	NULL
AM	NULL
,	NULL
Santoro	NULL
SA	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
apy	NULL
,	NULL
integrin	NULL
gene	NULL
expression	NULL
during	NULL
megakaryocytic	NULL
differentiation	NULL
of	NULL
K562	NULL
cells	NULL
:	NULL
Role	NULL
of	NULL
a	NULL
silencer	NULL
element	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:18441	NULL
,	NULL
1994	NULL
21	NULL
.	NULL

Sanger	NULL
F	NULL
,	NULL
Nicklen	NULL
S	NULL
,	NULL
Coulson	NULL
AR	NULL
:	NULL
DNA	NULL
sequencing	NULL
with	NULL
chain-termination	NULL
inhibitors	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
74:5463	NULL
,	NULL
1977	NULL
22	NULL
.	NULL

Zollet	NULL
MJ	NULL
,	NULL
Smith	NULL
M	NULL
:	NULL
Laboratory	NULL
methods	NULL
:	NULL
Oligonucleotide	NULL
ZUTTER	NULL
,	NULL
PAINTER	NULL
,	NULL
AND	NULL
YANG	NULL
directed	NULL
mutagenesis	NULL
:	NULL
A	NULL
simple	NULL
method	NULL
using	NULL
two	NULL
oligonucleotide	NULL
primers	NULL
and	NULL
a	NULL
single-stranded	NULL
DNA	NULL
template	NULL
.	NULL

DNA	NULL
3:479	NULL
,	NULL
1984	NULL
23	NULL
.	NULL

Shivdasani	NULL
RA	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
The	NULL
transcriptional	NULL
control	NULL
of	NULL
hemato-poiesis	NULL
.	NULL

Blood	NULL
87:4025	NULL
,	NULL
1996	NULL
24	NULL
.	NULL

Martin	NULL
F	NULL
,	NULL
Prandini	NULL
MH	NULL
,	NULL
Thevenon	NULL
D	NULL
,	NULL
Marguerie	NULL
G	NULL
,	NULL
Uzan	NULL
G	NULL
:	NULL
The	NULL
transcription	NULL
factor	NULL
GATA	NULL
regulated	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
platelet	NULL
glycoprotein	NULL
IIb	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:21606	NULL
,	NULL
1993	NULL
25	NULL
.	NULL

Uzan	NULL
G	NULL
,	NULL
Prenant	NULL
M	NULL
,	NULL
Prandini	NULL
MH	NULL
,	NULL
Martin	NULL
F	NULL
,	NULL
Margueri	NULL
G	NULL
:	NULL
Tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
platelet	NULL
GPIIb	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:8932	NULL
,	NULL
1991	NULL
26	NULL
.	NULL

Prandini	NULL
MH	NULL
,	NULL
Uzan	NULL
G	NULL
,	NULL
Martin	NULL
F	NULL
,	NULL
Thevenon	NULL
D	NULL
,	NULL
Marguerie	NULL
G	NULL
:	NULL
Characterization	NULL
of	NULL
a	NULL
specific	NULL
erythromegakaryocytic	NULL
enhancer	NULL
within	NULL
the	NULL
glycoprotein	NULL
IIb	NULL
promoter	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:10370	NULL
,	NULL
1992	NULL
27	NULL
.	NULL

Lemarchandel	NULL
V	NULL
,	NULL
Ghysdael	NULL
J	NULL
,	NULL
Mignotte	NULL
V	NULL
,	NULL
Rahuel	NULL
C	NULL
,	NULL
Roméo	NULL
PH	NULL
:	NULL
GATA	NULL
and	NULL
Ets	NULL
cis-acting	NULL
sequences	NULL
mediate	NULL
megakaryocyte-specific	NULL
expression	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:668	NULL
,	NULL
1993	NULL
28	NULL
.	NULL

Ravid	NULL
K	NULL
,	NULL
Doi	NULL
T	NULL
,	NULL
Beeler	NULL
DL	NULL
,	NULL
Kutter	NULL
DJ	NULL
,	NULL
Rosenberg	NULL
RD	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
rat	NULL
platelet	NULL
factor	NULL
4	NULL
gene	NULL
:	NULL
Interaction	NULL
between	NULL
an	NULL
enhancer/silencer	NULL
domain	NULL
and	NULL
the	NULL
GATA	NULL
site	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:6116	NULL
,	NULL
1991	NULL
29	NULL
.	NULL

Orkin	NULL
SH	NULL
:	NULL
GATA-binding	NULL
transcription	NULL
factors	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Blood	NULL
80:575	NULL
,	NULL
1992	NULL
30	NULL
.	NULL

Talbot	NULL
D	NULL
,	NULL
Grosveld	NULL
F	NULL
:	NULL
The	NULL
5'HS2	NULL
of	NULL
the	NULL
globin	NULL
locus	NULL
control	NULL
region	NULL
enhances	NULL
transcription	NULL
through	NULL
the	NULL
interaction	NULL
of	NULL
a	NULL
multimeric	NULL
complex	NULL
binding	NULL
at	NULL
two	NULL
functionally	NULL
distinct	NULL
NF-E2	NULL
binding	NULL
sites	NULL
.	NULL

EMBO	NULL
J	NULL
10:1391	NULL
,	NULL
1991	NULL
31	NULL
.	NULL

Martin	NULL
DI	NULL
,	NULL
Tsai	NULL
SF	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Increased	NULL
gamma-globin	NULL
expression	NULL
in	NULL
a	NULL
nondeletion	NULL
HPFH	NULL
mediated	NULL
by	NULL
an	NULL
erythroid-specific	NULL
DNA-binding	NULL
factor	NULL
.	NULL

Nature	NULL
338:435	NULL
,	NULL
1989	NULL
32	NULL
.	NULL

Strauss	NULL
EC	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
In	NULL
vivo	NULL
protein-DNA	NULL
interactions	NULL
at	NULL
hypersensitive	NULL
site	NULL
3	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
locus	NULL
control	NULL
region	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:5809	NULL
,	NULL
1992	NULL
33	NULL
.	NULL

Mitchell	NULL
PJ	NULL
,	NULL
Wang	NULL
C	NULL
,	NULL
Tjian	NULL
R	NULL
:	NULL
Positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
transcription	NULL
in	NULL
vitro	NULL
:	NULL
Enhancer-binding	NULL
protein	NULL
AP-2	NULL
is	NULL
inhibited	NULL
by	NULL
SV40	NULL
T	NULL
antigen	NULL
.	NULL

Cell	NULL
Press	NULL
50:847	NULL
,	NULL
1987	NULL
34	NULL
.	NULL

Imagawa	NULL
M	NULL
,	NULL
Chiu	NULL
R	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
Transcription	NULL
factor	NULL
AP-2	NULL
mediates	NULL
induction	NULL
by	NULL
two	NULL
different	NULL
signal-transduction	NULL
pathways	NULL
:	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
cAMP	NULL
.	NULL

Cell	NULL
Press	NULL
51:251	NULL
,	NULL
1987	NULL
35	NULL
.	NULL

Williams	NULL
T	NULL
,	NULL
Tjian	NULL
R	NULL
:	NULL
Analysis	NULL
of	NULL
the	NULL
DNA-binding	NULL
and	NULL
activation	NULL
properties	NULL
of	NULL
the	NULL
human	NULL
transcription	NULL
factor	NULL
AP-2	NULL
.	NULL

Genes	NULL
Dev	NULL
5:670	NULL
,	NULL
1991	NULL
36	NULL
.	NULL

Angel	NULL
P	NULL
,	NULL
Allegretto	NULL
EA	NULL
,	NULL
Okino	NULL
ST	NULL
,	NULL
Hattori	NULL
K	NULL
,	NULL
Boyle	NULL
WS	NULL
,	NULL
Hunter	NULL
T	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
Oncogene	NULL
jun	NULL
encodes	NULL
a	NULL
sequence-specific	NULL
trans-activator	NULL
similar	NULL
to	NULL
AP1	NULL
.	NULL

Nature	NULL
332:166	NULL
,	NULL
1988	NULL
37	NULL
.	NULL

Ivashkiv	NULL
SP	NULL
,	NULL
Liou	NULL
HC	NULL
,	NULL
Kara	NULL
CJ	NULL
,	NULL
Lamph	NULL
WW	NULL
,	NULL
Verma	NULL
IM	NULL
,	NULL
Glimcher	NULL
LH	NULL
:	NULL
mXBP/CRE-BP2	NULL
and	NULL
c-Jun	NULL
form	NULL
a	NULL
complex	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
cyclic	NULL
AMP	NULL
,	NULL
but	NULL
not	NULL
to	NULL
the	NULL
12-0-tetradecanoylphorbol-13-acetate	NULL
,	NULL
response	NULL
element	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:1609	NULL
,	NULL
1990	NULL
38	NULL
.	NULL

Gottlicher	NULL
M	NULL
,	NULL
Rahmsdorf	NULL
HJ	NULL
,	NULL
Herrlich	NULL
P	NULL
:	NULL
The	NULL
AP1	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
:	NULL
Multi-level	NULL
control	NULL
of	NULL
activity	NULL
,	NULL
in	NULL
Papavassiliou	NULL
AG	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Transcription	NULL
Factors	NULL
in	NULL
Eukaryotes	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Chapman	NULL
and	NULL
Hall	NULL
,	NULL
1997	NULL
,	NULL
p	NULL
67	NULL
39	NULL
.	NULL

Ahn	NULL
NG	NULL
,	NULL
Geger	NULL
R	NULL
,	NULL
Krebs	NULL
EG	NULL
:	NULL
The	NULL
MAP	NULL
kinase	NULL
cascade	NULL
:	NULL
Discovery	NULL
of	NULL
a	NULL
new	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Curr	NULL
Opin	NULL
Cell	NULL
Biol	NULL
4:992	NULL
,	NULL
1992	NULL
40	NULL
.	NULL

Whalen	NULL
AM	NULL
,	NULL
Galasinski	NULL
SC	NULL
,	NULL
Shapiro	NULL
PS	NULL
,	NULL
Nahreini	NULL
TS	NULL
,	NULL
Ahn	NULL
NG	NULL
:	NULL
Megakaryocytic	NULL
differentiation	NULL
induced	NULL
by	NULL
constitutive	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
kinase	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
17:1947	NULL
,	NULL
1997	NULL
41	NULL
.	NULL

Marshall	NULL
CJ	NULL
:	NULL
MAP	NULL
kinase	NULL
kinase	NULL
kinase	NULL
,	NULL
MAP	NULL
kinase	NULL
kinase	NULL
,	NULL
MAP	NULL
kinase	NULL
.	NULL

Curr	NULL
Opin	NULL
Genet	NULL
Dev	NULL
4:82	NULL
,	NULL
1994	NULL
42	NULL
.	NULL

Trouche	NULL
D	NULL
,	NULL
Robin	NULL
P	NULL
,	NULL
Sassone-Corsi	NULL
P	NULL
,	NULL
Farrar	NULL
WL	NULL
,	NULL
Harel-Bellan	NULL
A	NULL
:	NULL
The	NULL
dyad	NULL
symmetry	NULL
element	NULL
is	NULL
the	NULL
molecular	NULL
target	NULL
for	NULL
c-fos	NULL
induction	NULL
and	NULL
inhibition	NULL
during	NULL
K562	NULL
differentiation	NULL
along	NULL
mutually	NULL
exclusive	NULL
lineages	NULL
.	NULL

Blood	NULL
77:55	NULL
,	NULL
1991	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

MEGAKARYOCYTE	NULL
ENHANCER	NULL
OF	NULL
THE	NULL
«	NULL
B	NULL
,	NULL
INTEGRIN	NULL
GENE	NULL
43	NULL
.	NULL

Angel	NULL
P	NULL
,	NULL
Hattori	NULL
K	NULL
,	NULL
Smeal	NULL
T	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
The	NULL
jun	NULL
proto-oncogene	NULL
is	NULL
positively	NULL
autoregulated	NULL
by	NULL
its	NULL
product	NULL
,	NULL
Jun/AP-1	NULL
.	NULL

Cell	NULL
55:875	NULL
,	NULL
1988	NULL
44	NULL
.	NULL

Racke	NULL
FK	NULL
,	NULL
Lewandowska	NULL
K	NULL
,	NULL
Goueli	NULL
S	NULL
,	NULL
Goldfarb	NULL
AN	NULL
:	NULL
Sustained	NULL
activation	NULL
of	NULL
the	NULL
extracellular	NULL
signal-regulated	NULL
kinase/mitogen-activated	NULL
protein	NULL
kinase	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
megakaryocytic	NULL
differentiation	NULL
of	NULL
K562	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
272:23366	NULL
,	NULL
1997	NULL
45	NULL
.	NULL

Rouyez	NULL
MC	NULL
,	NULL
Boucheron	NULL
C	NULL
,	NULL
Gisselbrecht	NULL
S	NULL
,	NULL
Dusanter-Fourt	NULL
I	NULL
,	NULL
Porteu	NULL
F	NULL
:	NULL
Control	NULL
of	NULL
thrombopoietin-induced	NULL
megakaryocytic	NULL
differentiation	NULL
by	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathway	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
17:4991	NULL
,	NULL
1997	NULL
46	NULL
.	NULL

Hashimoto	NULL
Y	NULL
,	NULL
Ware	NULL
J	NULL
:	NULL
Identification	NULL
of	NULL
essential	NULL
GATA	NULL
and	NULL
Ets	NULL
binding	NULL
motifs	NULL
within	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
platelet	NULL
glycoprotein	NULL
Iba	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:24532	NULL
,	NULL
1995	NULL
47	NULL
.	NULL

Ramachandran	NULL
B	NULL
,	NULL
Surrey	NULL
S	NULL
,	NULL
Schwartz	NULL
E	NULL
:	NULL
Megakaryocyte-specific	NULL
positive	NULL
regulatory	NULL
sequency	NULL
5	NULL
'	NULL
to	NULL
the	NULL
human	NULL
PF4	NULL
gene	NULL
.	NULL

Exp	NULL
Hematol	NULL
23:49	NULL
,	NULL
1995	NULL
48	NULL
.	NULL

Deveaux	NULL
S	NULL
,	NULL
Filipe	NULL
A	NULL
,	NULL
Lemarchandel	NULL
V	NULL
,	NULL
Ghysdael	NULL
J	NULL
,	NULL
Roméo	NULL
PH	NULL
,	NULL
Mignotte	NULL
V	NULL
:	NULL
Analysis	NULL
of	NULL
the	NULL
thrombopoietin	NULL
receptor	NULL
(	NULL
MPL	NULL
)	NULL
promoter	NULL
implicates	NULL
GATA	NULL
and	NULL
Ets	NULL
proteins	NULL
in	NULL
the	NULL
co-regulation	NULL
of	NULL
megakaryocyte-specific	NULL
genes	NULL
.	NULL

Blood	NULL
87:4678	NULL
,	NULL
1996	NULL
49	NULL
.	NULL

Karin	NULL
M	NULL
:	NULL
The	NULL
regulation	NULL
of	NULL
API	NULL
activity	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:16483	NULL
,	NULL
1995	NULL
50	NULL
.	NULL

Angel	NULL
P	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
The	NULL
role	NULL
of	NULL
Jun	NULL
,	NULL
Fos	NULL
and	NULL
the	NULL
AP-1	NULL
complex	NULL
in	NULL
cell-proliferation	NULL
and	NULL
transformation	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1072:129	NULL
,	NULL
1991	NULL
51	NULL
.	NULL

Talbot	NULL
D	NULL
,	NULL
Grosveld	NULL
F	NULL
:	NULL
The	NULL
5'HS2	NULL
of	NULL
the	NULL
globin	NULL
locus	NULL
control	NULL
region	NULL
enhances	NULL
transcription	NULL
through	NULL
the	NULL
interaction	NULL
of	NULL
a	NULL
multimeric	NULL
complex	NULL
binding	NULL
at	NULL
two	NULL
functionally	NULL
distinct	NULL
NF-E2	NULL
binding	NULL
sites	NULL
.	NULL

EMBO	NULL
J	NULL
10:1391	NULL
,	NULL
1991	NULL
1611	NULL
52	NULL
.	NULL

Ney	NULL
PA	NULL
,	NULL
Sorrentino	NULL
BP	NULL
,	NULL
Lowrey	NULL
CH	NULL
,	NULL
Nienhuis	NULL
AW	NULL
:	NULL
Inducibility	NULL
of	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
depends	NULL
on	NULL
binding	NULL
of	NULL
an	NULL
erythroid	NULL
specific	NULL
nuclear	NULL
protein	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
18:6011	NULL
,	NULL
1990	NULL
53	NULL
.	NULL

Andrews	NULL
NC	NULL
,	NULL
Kotkow	NULL
KJ	NULL
,	NULL
Ney	NULL
PA	NULL
,	NULL
Erdjument-Bromage	NULL
H	NULL
,	NULL
Tempst	NULL
P	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
The	NULL
ubiquitous	NULL
subunit	NULL
of	NULL
erythroid	NULL
transcription	NULL
factor	NULL
NF-E2	NULL
is	NULL
a	NULL
small	NULL
basic-leucine	NULL
zipper	NULL
protein	NULL
related	NULL
to	NULL
the	NULL
v-maf	NULL
oncogene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:11488	NULL
,	NULL
1993	NULL
54	NULL
.	NULL

Mignotte	NULL
V	NULL
,	NULL
Wall	NULL
L	NULL
,	NULL
deBoer	NULL
E	NULL
,	NULL
Grosveld	NULL
F	NULL
,	NULL
Romeo	NULL
PH	NULL
:	NULL
Two	NULL
tissue-specific	NULL
factors	NULL
bind	NULL
the	NULL
erythroid	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
17:37	NULL
,	NULL
1989	NULL
55	NULL
.	NULL

Solomon	NULL
WB	NULL
,	NULL
Lin	NULL
CH	NULL
,	NULL
Palma	NULL
J	NULL
,	NULL
Gao	NULL
XY	NULL
,	NULL
Wu	NULL
S	NULL
:	NULL
Suppression	NULL
of	NULL
a	NULL
cellular	NULL
differentiation	NULL
program	NULL
by	NULL
phorbol	NULL
esters	NULL
coincides	NULL
with	NULL
inhibition	NULL
of	NULL
binding	NULL
of	NULL
a	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
(	NULL
NF-E2	NULL
)	NULL
to	NULL
an	NULL
enhancer	NULL
element	NULL
required	NULL
for	NULL
expression	NULL
of	NULL
an	NULL
erythroid-specific	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:5089	NULL
,	NULL
1993	NULL
56	NULL
.	NULL

Mignotte	NULL
V	NULL
,	NULL
Navarro	NULL
S	NULL
,	NULL
Eleouet	NULL
JF	NULL
,	NULL
Zon	NULL
LI	NULL
,	NULL
Romeo	NULL
PH	NULL
:	NULL
The	NULL
extinction	NULL
of	NULL
erythroid	NULL
genes	NULL
after	NULL
tetradecanoylphorbol	NULL
acetate	NULL
treatment	NULL
of	NULL
erythroleukemic	NULL
cells	NULL
correlates	NULL
with	NULL
downregulation	NULL
of	NULL
the	NULL
tissue-specific	NULL
factors	NULL
NF-E1	NULL
and	NULL
NF-E2	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
265:22090	NULL
,	NULL
1990	NULL
57	NULL
.	NULL

Mu	NULL
SX	NULL
,	NULL
Xia	NULL
M	NULL
,	NULL
Ellliot	NULL
G	NULL
,	NULL
Bogenberger	NULL
J	NULL
,	NULL
Swift	NULL
S	NULL
,	NULL
Bennett	NULL
L	NULL
,	NULL
Lappinga	NULL
DL	NULL
,	NULL
Hetcht	NULL
R	NULL
,	NULL
lee	NULL
R	NULL
,	NULL
Saris	NULL
CJM	NULL
:	NULL
Megakaryocyte	NULL
growth	NULL
and	NULL
development	NULL
factor	NULL
and	NULL
interleukin-3	NULL
induce	NULL
patterns	NULL
of	NULL
protein-tyrosine	NULL
phosphorylation	NULL
that	NULL
correlate	NULL
with	NULL
dominant	NULL
differentiation	NULL
over	NULL
proliferation	NULL
of	NULL
mpl-transfected	NULL
32D	NULL
cells	NULL
.	NULL

Blood	NULL
86:4532	NULL
,	NULL
1995	NULL
58	NULL
.	NULL

Nagata	NULL
Y	NULL
,	NULL
Nishida	NULL
E	NULL
,	NULL
Todokoro	NULL
K	NULL
:	NULL
Activation	NULL
of	NULL
JNK	NULL
signaling	NULL
pathway	NULL
by	NULL
erythropoietin	NULL
,	NULL
thrombopoietin	NULL
,	NULL
and	NULL
interleukin-3	NULL
.	NULL

Blood	NULL
89:2664	NULL
,	NULL
1997	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GUY	NULL
o	NULL
;	NULL
.	NULL

4	NULL
25	NULL
00	NULL
1999	NULL
93	NULL
:	NULL
1600-1611	NULL
¥®	NULL
The	NULL
Megakaryocyte/Platelet-Specific	NULL
Enhancer	NULL
of	NULL
the	NULL
?	NULL

5f4	NULL
Integrin	NULL
Gene	NULL
:	NULL
Two	NULL
Tandem	NULL
AP1	NULL
Sites	NULL
and	NULL
the	NULL
Mitogen-Activated	NULL
Proteln	NULL
Kinase	NULL
Signaling	NULL
Cascade	NULL
“	NULL
New	NULL
Ow	NULL
Mary	NULL
M.	NULL
Zutter	NULL
,	NULL
Audrey	NULL
D.	NULL
Painter	NULL
and	NULL
Xun	NULL
Yang	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Hemostasis	NULL
,	NULL
Thrombosis	NULL
,	NULL
and	NULL
Vascular	NULL
Biology	NULL
(	NULL
2485	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

